<SEC-DOCUMENT>0000950142-24-002872.txt : 20241203
<SEC-HEADER>0000950142-24-002872.hdr.sgml : 20241203
<ACCEPTANCE-DATETIME>20241203082220
ACCESSION NUMBER:		0000950142-24-002872
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241203
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241203
DATE AS OF CHANGE:		20241203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RED ROBIN GOURMET BURGERS INC
		CENTRAL INDEX KEY:			0001171759
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				841573084
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34851
		FILM NUMBER:		241521239

	BUSINESS ADDRESS:	
		STREET 1:		10000 EAST GEDDES AVENUE
		STREET 2:		SUITE 500
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		3038466000

	MAIL ADDRESS:	
		STREET 1:		10000 EAST GEDDES AVENUE
		STREET 2:		SUITE 500
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eh240546757_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:RRGB="http://redrobin.com/20241203">
<head>
     <title>FORM 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_RRGB_redrobin.com_20241203 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20241203_20241203 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001171759 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000004" name="dei:EntityCentralIndexKey">0001171759</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rrgb-20241203.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-12-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001171759</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-03</xbrli:startDate>
        <xbrli:endDate>2024-12-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><b>FORM&#160;<span id="xdx_907_edei--DocumentType_c20241203__20241203_zA4NfKqspMYf"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Pursuant to Section&#160;13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_902_edei--DocumentPeriodEndDate_c20241203__20241203_zeABq0b1jrjk"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 3, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20241203__20241203_zKblmibDJP6g"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000011" name="dei:EntityRegistrantName">RED ROBIN GOURMET BURGERS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt; border-collapse: collapse">
  <tr>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 33%; text-align: center"><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20241203__20241203_zSijEzfJc0h2"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityFileNumber_c20241203__20241203_z3IcrqBKsli2"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000013" name="dei:EntityFileNumber">001-34851</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20241203__20241203_zEM4DgJfIwic"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000014" name="dei:EntityTaxIdentificationNumber">84-1573084</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">(State or other jurisdiction of</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.4pt; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.4pt; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_904_edei--EntityAddressAddressLine1_c20241203__20241203_zjE5ywh5jrg8"><b><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000015" name="dei:EntityAddressAddressLine1">10000
E. Geddes Avenue</ix:nonNumeric></b></span><b>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20241203__20241203_zxY7Est0Czr1"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 500</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20241203__20241203_zX7qiV4B1VZ9"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000017" name="dei:EntityAddressCityOrTown">Englewood</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20241203__20241203_z0YfSJBHl062"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span></b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20241203__20241203_zXitpaqsmQ0l"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000019" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b>(<span id="xdx_904_edei--CityAreaCode_c20241203__20241203_zPmZnQ01Led8"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000020" name="dei:CityAreaCode">303</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20241203__20241203_z2ACSLI6J1yg"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000021" name="dei:LocalPhoneNumber">846-6000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s telephone number, including area
code)</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--WrittenCommunications_c20241203__20241203_zfi58XMCzN4k"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--SolicitingMaterial_c20241203__20241203_zUg15KS94fT6"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20241203__20241203_zn7stTBTV2Ie"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20241203__20241203_zCZ5cf6xS5o"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 33%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Title of each class</p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 30%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Trading<br/>
    symbol(s)</p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 35%">
    <p style="border-bottom: black 0pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Name of each exchange
    on which</p>
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">registered</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20241203__20241203_zkbg0APvjHs1"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20241203__20241203_zDorKxjo6G2h"><ix:nonNumeric contextRef="AsOf2024-12-03" id="Fact000027" name="dei:TradingSymbol">RRGB</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--SecurityExchangeName_c20241203__20241203_zb5LMwy5VUQb"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> (Global Select Market)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Arial Unicode MS; margin: 0 0 0pt">&#160;</p>

<p style="font: 10pt Arial Unicode MS; margin: 0 0 0pt"><span style="font-family: Times New Roman, Times, Serif">Emerging growth company&#160;</span><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20241203__20241203_zIRAl4Ku4FBj"><ix:nonNumeric contextRef="AsOf2024-12-03" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial Unicode MS; margin: 0 0 0pt">&#160;</p>

<p style="font: 10pt Arial Unicode MS; margin: 0 0 0pt"><span style="font-family: Times New Roman, Times, Serif">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&#160;</p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->





<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item&#160;1.01</b></td><td><b>Entry into Material Definitive Agreement.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white"><i>Cooperation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">On December
3, 2024, Red Robin Gourmet Burgers, Inc. (the &#8220;Company&#8221;) entered into a cooperation agreement (the &#8220;Cooperation Agreement&#8221;)
with the entities and persons listed on Exhibit A thereto (the &#8220;JCP Parties&#8221;) and the entities and persons listed on Exhibit
B thereto (the &#8220;Jumana Parties,&#8221; and together with the JCP Parties, the &#8220;Investor Parties&#8221;). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">Pursuant
to the Cooperation Agreement, the Company agreed, among other things, to immediately appoint James C. Pappas (&#8220;Mr. Pappas&#8221;)
and Christopher Martin (&#8220;Mr. Martin,&#8221; and together with Mr. Pappas, the &#8220;New Directors,&#8221; and each a &#8220;New
Director&#8221;) to the board of directors of the Company (the &#8220;Board&#8221;) and increase the size of the Board to ten directors,
to accommodate the appointment of the New Directors. As long as each of the Investor Parties continue to satisfy the Minimum Ownership
Threshold (as defined below), each of the New Directors will be nominated by the Board to stand for election at each annual meeting of
stockholders held during the Cooperation Period (as defined below). The Company has also agreed that, until the expiration of the Cooperation
Period, the size of the Board will not exceed ten directors, without the prior written consent of the Investor Parties. Each of the New
Directors will be appointed to the Finance Committee of the Board (the &#8220;Finance Committee&#8221;) as soon as reasonably practicable
following his appointment to the Board. Following the appointment of the New Directors to the Finance Committee until the expiration of
the Cooperation Period, the size of the Finance Committee will be no greater than five members, without the prior written consent of the
Investor Parties. Tom Conforti will continue to serve as Chair of the Finance Committee. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">Pursuant
to the Cooperation Agreement, the Investor Parties have agreed to abide by certain standstill restrictions and voting commitments, subject
to certain limited exceptions, during the Cooperation Period. The Cooperation Agreement also includes procedures regarding the replacement
of the New Directors and a mutual non-disparagement provision. The right of the Investor Parties to participate in the selection of any
replacement New Director, and the Company&#8217;s obligations with respect to the appointment of such replacement New Director, is subject,
among other things, to (1) in the case of the right of the JCP Parties to designate any replacement New Director, the JCP Parties collectively
holding a &#8220;net long position&#8221; equal to, or having aggregate net long economic exposure to, at least 5.0% of the Company&#8217;s
then-outstanding common stock (the &#8220;Minimum Ownership Threshold&#8221;) and (2) in the case of the right of the Jumana Parties to
designate any replacement New Director, the Jumana Parties collectively holding a &#8220;net-long position&#8221; of, or having aggregate
net long economic exposure to, at least the Minimum Ownership Threshold. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">The Cooperation
Agreement will remain effective until the earlier of (1) the date that is 30 calendar days prior to the advance notice deadline set forth
in the Company&#8217;s Fifth Amended and Restated Bylaws (as amended or restated from time to time, the &#8220;Bylaws&#8221;) for the
stockholder nomination of non-proxy access director candidates for election to the Board at the Company&#8217;s Annual Meeting of Stockholders
during the Company&#8217;s fiscal year 2026 (the &#8220;2026 Annual Meeting&#8221;) and (2) 120 calendar days prior to the first anniversary
of the Company&#8217;s Annual Meeting of Stockholders during the Company&#8217;s fiscal year 2025 (the &#8220;2025 Annual Meeting&#8221;)
(collectively, the &#8220;2026 Advance Notice Window&#8221;); provided, however, that the conclusion of the Cooperation Period shall be
extended and delayed until the date that is the earlier of (x) 30 calendar days prior to the advance notice deadline set forth in the
Bylaws for the stockholder nomination of non-proxy access director candidates for election to the Board at the Company&#8217;s Annual
Meeting of Stockholders during the Company&#8217;s fiscal year 2027 and (y) 120 calendar days prior to the first anniversary of the 2026
Annual Meeting if (A) the Company determines to and irrevocably offers to re-nominate the New Directors for election at the 2026 Annual
Meeting, provided that the Company notifies the New Directors in writing at least 15 calendar days prior to the opening of the 2026 Advance
Notice Window of such determination and offers to irrevocably re-nominate the New Directors for election at the 2026 Annual Meeting and
(B) the New Directors agree to such nomination within 15 calendar days of receipt of such notice (such period, the &#8220;Cooperation
Period&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">The foregoing
summary of the Cooperation Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of
the form of Cooperation Agreement, a copy of which is attached as Exhibit 10.1 and is incorporated by reference.</span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: white"><i>Equity Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">On December
3, 2024, the Company entered into an equity purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain affiliates of the Investor
Parties, (the &#8220;Equity Investors&#8221;), pursuant to which the Company agreed to issue and sell to the Equity Investors in a private
placement (the &#8220;Private Placement&#8221;) an aggregate of </span>1,600,909 shares (the &#8220;Shares&#8221;) of the Company&#8217;s
common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at a purchase price of $5.19 per share. <span style="background-color: white">The
aggregate gross proceeds from the Private Placement are expected to be approximately $</span>8.3 million<span style="background-color: white">.
The Company anticipates net proceeds from the Private Placement will be used to repay indebtedness and for general corporate expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">Following
the closing of the Private Placement, the Company will have approximately </span>17,387,048 <span style="background-color: white">outstanding
shares of Common Stock. The Purchase Agreement contains customary representations, warranties and agreements by the Company and the Equity
Investors, indemnification obligations of the Company and the Equity Investors, including for liabilities under the Securities Act of
1933, as amended (the &#8220;Securities Act&#8221;), and other obligations of the parties. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">In addition,
the Purchase Agreement provides certain customary registration rights, pursuant to which the Company has agreed to use commercially reasonable
efforts to file a registration statement with the </span>Securities and Exchange Commission (the &#8220;<span style="background-color: white">SEC&#8221;)
covering the resale by the Equity Investors of their Shares within 45 days following the closing of the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">The Private
Placement is exempt from the registration requirements of the Securities Act pursuant to the exemption for transactions by an issuer not
involving any public offering under Section 4(a)(2) of the Securities Act and in reliance on similar exemptions under applicable state
laws. The Company relied on this exemption from registration based in part on representations made by the Equity Investors. The securities
sold and issued in the Private Placement are not registered under the Securities Act or any state securities laws and may not be offered
or sold in the United States absent registration with the SEC or any applicable exemption from the registration requirements. Neither
this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an offer to buy the securities
described herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">Under
the terms of the Purchase Agreement, (i) the Board has exempted the Purchase Agreement, the Cooperation Agreement and the transactions
contemplated thereby from the provisions of Section 203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) and (ii) the
Equity Investors have agreed that, immediately upon the Equity Investors (together with their respective affiliates) acquiring beneficial
ownership, or becoming the beneficial owner, of 21.0% or more of the outstanding shares of Common Stock without prior Board approval,
(A) the Equity Investors (together with their respective affiliates, as applicable) will be considered an &#8220;interested stockholder&#8221;
of the Company as defined in Section 203 of the DGCL (but, for this purpose, replacing 15% in such definition with 21.0%) as if the exemption
from Section 203 of the DGCL had not been granted and (B) the Company shall be subject to the restrictions on any business combination
(as defined in Section 203 of the DGCL) with the Equity Investors (together with their respective affiliates, as applicable) as an &#8220;interested
stockholder&#8221; enumerated in Section 203 of the DGCL for a period of three years following such time the Equity Investors (together
with their respective affiliates) came to beneficially own 21.0% or more of the outstanding shares of Common Stock; provided that for
purposes of the foregoing ownership limitation, it is understood and agreed that any securities acquired or underlying any award or grant
from the Company with respect to a Restricted Person&#8217;s (as defined in the Cooperation Agreement) service as a director, officer
or employee of the Company shall be excluded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><span style="background-color: white">The foregoing
summary of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the
form of Purchase Agreement, a copy of which is attached as Exhibit 10.2 and is incorporated by reference.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item&#160;3.02</b></td><td><b>Unregistered Sale of Equity Securities. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white; text-indent: 0.5in">The information set
forth in Item 1.01 is incorporated herein by reference.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item&#160;5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">The information set forth in Item 1.01 is incorporated
herein by reference.</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Pursuant to the Cooperation Agreement, on December
3, 2024, the Board increased its size from eight to ten members and appointed each of the New Directors to fill the resulting vacancies.
Mr. Pappas founded JCP Investment Management in Houston in June 2009 and is the Managing Member and owner of the firm. He has served as
a director of United Natural Foods, Inc. (NYSE: UNFI), a food distributor to grocery stores, since September 2023. Additionally, he has
been the chairman of the board of directors of Innovative Food Holdings, Inc. (OTCQB: IVFH), a direct-to-chef and restaurant specialty
food platform, since 2023, and a director since 2020. Mr. Pappas is also a director of Tandy Leather Factory, Inc. (NASDAQ: TLF), a specialty
retailer and wholesale distributor of leather and leather related products, a position he has held since 2016. Mr. Pappas previously served
on the boards of several other public companies, including food-related businesses such as Jamba, Inc., The Pantry, Inc., and Morgan&#8217;s
Foods, Inc., as well as U.S. Geothermal Inc. From 2007 until 2009, he was a private investor, in addition to consulting with several businesses.
From 2005 until 2007, he worked in the Investment Banking/Leveraged Finance Division of Goldman Sachs, where he advised private equity
groups and corporations on appropriate leveraged buyout, recapitalization and refinancing alternatives. Prior to that, he was an investment
banker at Banc of America Securities, where he focused on consumer and retail investment banking. He currently also serves as Secretary
for the Endowment Advisory Board of the Annunciation Greek Orthodox Church in Houston and on the Methodist Hospital Gastro Division&#8217;s
Advisory Board in Houston. Mr. Pappas received a BBA in Information Technology, and a Master of Finance from Texas A&amp;M University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Mr. Martin has served as a Managing Director
of Jumana Capital, LLC, a private investment firm specializing in concentrated investments in middle market companies, since July 2020,
where he is responsible for investment strategy and execution across the portfolio, and serves as the Manager of Jumana Capital Investments
LLC, an affiliated investment entity. Previously, Mr. Martin served as a Vice President at Hastings Equity Partners, LLC, a private equity
firm, from July 2017 until July 2020. Mr. Martin also previously served as the Chief Financial Officer of Specialty Welding &amp; Turnarounds,
LLC, an industrial services company, from October 2017 through January 2020. Prior to that, Mr. Martin was a Vice President at Simmons
&amp; Company International, part of the Piper Sandler Companies (NYSE: PIPR), from July 2013 to July 2017. Mr. Martin began his career
at FTI Consulting, Inc. (NYSE: FCN), a global advisory firm, in the Corporate Finance and Restructuring group. Mr. Martin holds an MBA
from the University of Texas at Austin and a BBA from Texas Christian University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Each of the New Directors will receive compensation
consistent with that received by the Company&#8217;s other non-employee directors, as described in the Company&#8217;s proxy statement
on Schedule 14A for the 2024 Annual Meeting of Stockholders, filed with the SEC on April 4, 2024. There are no arrangements or understandings
between any of the New Directors and any other person pursuant to which any of the New Directors was appointed as a director other than
with respect to the matters referred to in Item 1.01. At this time, there are no related party transactions in which any of the New Directors
has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The Board has determined that each of the New Directors qualifies as an independent
director under the Nasdaq listing standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">Upon their respective appointments to the Board,
Mr. Pappas and Mr. Martin each joined the Finance Committee of the Board.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item&#160;7.01</b></td><td><b>Regulation FD Disclosure. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in; background-color: white">On December 3, 2024,
the Company issued a press release announcing the Company&#8217;s entry into the Cooperation Agreement, the Purchase Agreement and the
matters described in Item 1.01, Item 3.02 and Item 5.02 of this Form 8-K. A copy of the press release is furnished as Exhibit 99.1 and
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in; background-color: white">As provided in General
Instruction B.2 of Form 8-K, the information under this Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as shall be expressly set forth by specific reference in such a filing.</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white"><b>Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in; background-color: white">Forward-looking statements
in this Form 8-K and certain of the materials furnished or filed herewith regarding our future operating or financial performance, our
strategy and ability to executive and drive long term shareholder value, the expected activities in connection with the Investor Parties,
and all other statements that are not historical facts are made under the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These statements are based on assumptions believed by the Company to be reasonable and speak only as of the date on
which such statements are made. Without limiting the generality of the foregoing, words such as &#8220;expect,&#8221; &#8220;believe,&#8221;
&#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;could,&#8221; &#8220;should,&#8221;
&#8220;will,&#8221; &#8220;outlook&#8221; or &#8220;estimate,&#8221; or the negative or other variations thereof or comparable terminology
are intended to identify forward-looking statements. Except as required by law, the Company undertakes no obligation to update such statements
to reflect events or circumstances arising after such date and cautions investors not to place undue reliance on any such forward-looking
statements. Forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially
from those cautionary statements and risk factors described from time to time in the Company&#8217;s Form 10-K, Form 10-Q, and Form 8-K
reports (including all amendments to those reports) filed with the U.S. Securities and Exchange Commission.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item&#160;9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 27.35pt; background-color: white">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>




<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 10%"><b>Exhibit No.</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 88%"><b>Description</b></td></tr>
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="eh240546757_ex1001.htm">Form of Cooperation Agreement</a></span></td></tr>
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="eh240546757_ex1002.htm">Form of Equity Purchase Agreement</a></span></td></tr>
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><a href="eh240546757_ex9901.htm">Red Robin Gourmet Burgers, Inc. Press Release dated December 3, 2024</a></p>
    </td></tr>
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>




<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0pt 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">Date:&#160;December 3, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; border-left-width: 0in; border-left-color: Black">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RED ROBIN GOURMET BURGERS, INC.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid">/s/ Todd Wilson</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todd Wilson</span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Arial Unicode MS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Arial Unicode MS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font-family: Arial Unicode MS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial
    Officer</span></td>
    <td style="font-family: Arial Unicode MS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5lprUH7CPFi1iFSkivga7SrDNlk38O5K3NLaIy8KyzHwzQgxETktTI8NxXhawx6attUco8YyM9oTBka3WKYRb4sU4z9r67v2BGQUGAzOJldRB6Kx347BKQamhHA0TBXKajmew24joq2dkz6ZC642uQdsKdkwtG/SaX33CXj/JUvPqqg7IzpANcbHs5TckUiWwpbt+EF8dFEUmokE3kciZbu235uY8NbCosQldrkf/G30AFp9JSA== -->


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>eh240546757_ex1001.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT 10.1</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">COOPERATION AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">This Cooperation Agreement
(this &ldquo;<B>Agreement</B>&rdquo;), dated as of December 3, 2024 (the &ldquo;<B>Effective Date</B>&rdquo;), is by and among Red Robin
Gourmet Burgers, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), the entities and persons listed on Exhibit A hereto
(the &ldquo;<B>JCP Parties</B>&rdquo;) and the entities and persons listed on Exhibit B hereto (the &ldquo;<B>Jumana Parties</B>&rdquo;).
The JCP Parties and the Jumana Parties are collectively referred to herein as the &ldquo;<B>Investor Parties</B>,&rdquo; and each of the
collective Investor Parties, respectively, an &ldquo;<B>Investor Party</B>.&rdquo; Capitalized terms in this Agreement shall have the
meanings set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, as of the date
of this Agreement, the JCP Parties beneficially own an aggregate of 1,060,213 shares of Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, as of the date
of this Agreement, the Jumana Parties beneficially own an aggregate of 814,452 shares of Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, the Company and
the Investor Parties have engaged in discussions related to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, concurrently herewith,
the Company and the Investor Parties are entering into that certain Equity Purchase Agreement, dated as of December 3, 2024 (the &ldquo;<B>Purchase
Agreement</B>&rdquo;), pursuant to which the Investor Parties will become the holders of an additional 1,600,909 shares of Common Stock,
in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, in furtherance
of such discussions and in connection with the investment contemplated by the Purchase Agreement, the Company and the Investor Parties
desire to enter into an agreement regarding the appointment of certain new, independent directors to the Board of Directors of the Company
(the &ldquo;<B>Board</B>&rdquo;) and certain other matters, in each case, on the terms and subject to the conditions set forth herein;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, the Board and
the Nominating and Governance Committee thereof (the &ldquo;<B>Nominating Committee</B>&rdquo;) have considered the qualifications of
James C. Pappas (&ldquo;<B>Mr. Pappas</B>&rdquo;) and Christopher Martin (&ldquo;<B>Mr. Martin</B>,&rdquo; and together with Mr. Pappas,
the <B>&ldquo;New Directors</B>,&rdquo; and each, a &ldquo;<B>New Director</B>&rdquo;) and determined that each of Mr. Pappas and Mr.
Martin satisfies the Board&rsquo;s criteria for the selection of directors and otherwise should be elected to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">NOW, THEREFORE, in consideration
of and reliance upon the promises, representations, mutual covenants and agreements contained herein, and for other good and valuable
consideration the receipt and sufficiency of which are hereby acknowledged, the Investor Parties and the Company agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Board of Directors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>New Directors</U>. Upon the Effective Date, the Board and all applicable committees thereof shall take (or shall have taken)
such actions as are necessary to increase the size of the Board by two (2) and immediately appoint Mr. Pappas (together with any Replacement
Investor Designee taking his position on the Board pursuant to <U>Section 1(e)</U>, the &ldquo;<B>JCP</B> Designee&rdquo;) and Mr. Martin (together with
any Replacement Investor Designee taking his position on the Board pursuant to <U>Section 1(e)</U>, the &ldquo;<B>Jumana Designee</B>&rdquo;)
as members of the Board to fill the vacancies created by such increase in the Board, with an initial term expiring at the Company&rsquo;s
Annual Meeting of Stockholders held in the Company&rsquo;s fiscal year 2025 (the &ldquo;<B>2025 Annual Meeting</B>&rdquo;).</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>New Director Agreements, Arrangements, and Understandings</U>. Each of the Investor Parties represents, warrants, and agrees
solely on behalf of itself that neither it nor any of its Affiliates (i) has paid or will pay any compensation to any of the New Directors
(including any Replacement Investor Designee contemplated by <U>Section 1(e)</U>) for such individual&rsquo;s nomination to or service
on the Board or (ii) has or will have any agreement, arrangement or understanding, written or oral, with any of the New Directors (including
any Replacement Investor Designee contemplated by <U>Section 1(e))</U> in connection with such individual&rsquo;s service as, or actions
taken in their capacities as, a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Meeting Nominees</U>. The Company and all applicable committees thereof shall take such actions as are necessary so that
the slate of nominees recommended by the Board in the Company&rsquo;s proxy statement and on its proxy card relating to each annual meeting
of stockholders held during the Cooperation Period shall include the New Directors and up to eight (8) other nominees selected by the
Board to stand for election at such annual meeting of stockholders. The Company shall recommend in favor of and solicit proxies for the
election of the New Directors at each annual meeting of stockholders held during the Cooperation Period in the same manner as the Board
recommends in favor of and solicits proxies for the Company&rsquo;s other director nominees. Notwithstanding anything to the contrary
in this Agreement, from and after any time the JCP Parties, on the one hand, or the Jumana Parties, on the other hand, cease to have replacement
rights pursuant to <U>Section 1(e)</U>, the Company shall have no obligation with respect to the matters set forth in this <U>Section
1(c)</U> with respect to, as applicable, the JCP Designee , on the one hand, or Jumana Designee, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Committees</U>. As soon as reasonably practicable following the appointment of the New Directors to the Board in accordance
with <U>Section 1(a)</U>, the Board and all applicable committees of the Board shall take such actions as are necessary to appoint both
of the New Directors to the Finance Committee of the Board (the &ldquo;<B>Finance Committee</B>&rdquo;). From the appointment of the New
Directors to the Finance Committee in accordance with this <U>Section 1(d)</U> until the expiration of the Cooperation Period, the size
of the Finance Committee shall be no greater than five (5) members without the prior written consent of the Investor Parties. Following
the appointment of the New Directors to the Finance Committee in accordance with this <U>Section 1(d)</U>, Tom Conforti shall continue
to serve as Chair of the Finance Committee, unless and until replaced as such by the Board. In addition, without limiting the foregoing,
the Board shall give each of the New Directors the same due consideration for membership to any committee of the Board as any other independent
director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Replacement Investor Designee</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If a New Director is unable or unwilling to serve as a director, resigns as a director, is removed as a director, or ceases to
be a director for any other reason prior to the expiration of the Cooperation Period, each of the Company and</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">(x) in the case of the JCP Designee,
the JCP Parties, and (y) in the case of the Jumana Designee, the Jumana Parties, shall cooperate in good faith to identify and mutually
agree, subject to <U>Section 1(f)</U> and <U>Section 1(g)</U>, upon a substitute Qualified Director (such individual, a &ldquo;<B>Replacement
Investor Designee</B>&rdquo;), and the Board shall take such actions as are necessary to appoint the Replacement Investor Designee to
serve as a director of the Company and to all applicable committees of the Board on which the New Director departing from the Board served
for the remainder of such New Director&rsquo;s term, subject to the approval (not to be unreasonably withheld, conditioned or delayed)
by the Nominating Committee, after conducting a good faith customary due diligence process consistent with its fiduciary duties and customary
practice. Effective upon the appointment of the Replacement Investor Designee to the Board, such Replacement Investor Designee will be
considered a New Director for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The JCP Parties&rsquo; rights pursuant to this <U>Section 1(e)</U> to designate any Replacement Investor Designee are subject to
the JCP Parties collectively holding a Net Long Position equal to, or having aggregate net long economic exposure to, at least the lesser
of (x) 5.0% of the then-outstanding Common Stock and (y)&nbsp;869,467 shares of Common Stock (subject to adjustment for stock splits,
reclassifications, combinations, and similar adjustments) (the &ldquo;<B>Minimum Ownership Threshold</B>&rdquo;). The Jumana Parties&rsquo;
rights pursuant to this <U>Section 1(e)</U> to designate any Replacement Investor Designee are subject to the Jumana Parties collectively
holding a Net Long Position equal to, or having aggregate net long economic exposure to, at least the Minimum Ownership Threshold. In
the event any Investor Party seeks to exercise their rights pursuant to this <U>Section 1(e)</U>, such Investor Party shall certify in
writing to the Company that the Minimum Ownership Threshold has been satisfied as of the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During the Cooperation Period, any Replacement Investor Designee designated pursuant to this <U>Section 1(e)</U> replacing a New
Director prior to the mailing of the Company&rsquo;s definitive proxy statement for the Company&rsquo;s applicable annual meeting of stockholders
shall stand for election at such meeting together with the Company&rsquo;s other director nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Replacement Investor Designee Information</U>. The Investor Parties acknowledge, as a condition to any Replacement Investor
Designee&rsquo;s appointment to the Board, such individual shall have promptly provided to the Company (i) any consent and information
the Company reasonably requests in connection with such appointment, including completion of the Company&rsquo;s standard forms, D&amp;O
questionnaires, representation agreements (in each case, substantially in the form completed by the Company&rsquo;s incumbent non-management
directors) and other customary onboarding and/or nomination documentation, and an executed consent to be named as a nominee in the Company&rsquo;s
proxy statement and to serve as a director if so elected for the full term for which such individual is elected at any Company meeting
of stockholders, in each case, as provided by the Company, (ii) information requested by the Company that is required to be disclosed
in a proxy statement or other filing under any applicable law, stock exchange rule, or listing standard, or as may be requested or required
by any regulatory or governmental authority having jurisdiction over the Company or its Affiliates, (iii) information reasonably requested
by the Company in connection with assessing eligibility, independence, and other criteria applicable to directors or satisfying compliance
and legal obligations, (iv) any written consent reasonably requested by the Company for the conduct of
the Company&rsquo;s vetting procedures generally applicable to non-management directors of the Company, and (v) such other information
reasonably requested by the Company, including such information as is necessary or appropriate for the Company or its agents to perform
a background check in the manner generally performed for non-management directors of the Company, including any one or more executed consents
to such background check and the execution of any one or more documents required by the Company of non-management directors of the Company
to assure compliance with <U>Section 1(e)</U> and <U>Section 1(g)</U>.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Policies</U>. The parties acknowledge that each New Director, upon election or appointment to the Board, will be governed
by the same protections and obligations regarding confidentiality, conflicts of interest, related person transactions, fiduciary duties,
codes of conduct, trading, and disclosure policies, director resignation policy, stock ownership guidelines, and other governance guidelines
and policies of the Company as other directors of the Company (collectively, &ldquo;<B>Company Policies</B>&rdquo;), and shall have the
same rights and benefits, including with respect to insurance, indemnification, compensation, and fees, as are applicable to all non-management
directors of the Company. The Company acknowledges that (i)&nbsp;no Company Policy shall be violated by any New Director receiving indemnification
and/or reimbursement of expenses from the Investor Parties or their respective Affiliates, <U>provided</U> that no New Director either
accepts or receives compensation from the Investor Parties or their respective Affiliates with respect to such New Director&rsquo;s service
or action as a director of the Company, (ii) other than the New Directors, the Company Policies do not apply to any of the Investor Parties
and their Affiliates as a result of the New Directors&rsquo; appointment to, or service on, the Board, including Company Policies with
respect to trading in the Company&rsquo;s securities, as they are not directors or employees of the Company, and (iii) no Company Policy
currently does, and no Company Policy at any time during the Cooperation Period will, prohibit any member of the Board (including any
New Director) from communicating with the Investor Parties or their Representatives, subject to such director&rsquo;s compliance with
the obligations applicable to members of the Board pursuant to the Company Policies (including confidentiality obligations) and such director&rsquo;s
fiduciary duties to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conflicts</U>. Each of the Investor Parties and the New Directors confirm that (i) the JCP Designee will recuse himself or herself
from any such portions of Board or committee meetings, if any, involving actual conflicts between the Company and the JCP Parties and
(ii) the Jumana Designee will recuse himself or herself from any such portions of Board or committee meetings, if any, involving actual
conflicts between the Company and the Jumana Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Board Size</U>. Notwithstanding anything to the contrary in this Agreement, until the expiration of the Cooperation Period,
the size of the Board shall be no greater than ten (10) members without the prior written consent of the Investor Parties.</P>




<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination</U>. The rights and obligations of the Company and the Investor Parties under this <U>Section 1</U> shall terminate
upon the earlier of: (i) with respect to the JCP Parties, such time as (A) at any time on or after December 2, 2025, the JCP Parties collectively
do not satisfy the Minimum Ownership Threshold, (B) the JCP Designee notifies the Company of his or her intent to resign from the Board
and the JCP Parties irrevocably waive in writing any right to have a Replacement Investor Designee appointed,
(C) any material breach of this Agreement (including <U>Section 2</U>) by any JCP Party or any of their Restricted Persons upon five (5)
Business Days&rsquo; written notice by the Company to the JCP Parties if such breach has not been cured by the end of such notice period;
<U>provided</U> that the Company is not in material breach of this Agreement at the time such notice is given or during the notice period,
or (D) the JCP Parties or any of their Restricted Persons submits any director nomination for election at any meeting of the Company&rsquo;s
stockholders, (ii) with respect to the Jumana Parties, such time as (A) at any time on or after December 2, 2025, the Jumana Parties collectively
do not satisfy the Minimum Ownership Threshold, (B) the Jumana Designee notifies the Company of his or her intent to resign from the Board
and the Jumana Parties irrevocably waive in writing any right to have a Replacement Investor Designee appointed, (C) any material breach
of this Agreement (including <U>Section 2</U>) by any Jumana Party or any of their Restricted Persons upon five (5) Business Days&rsquo;
written notice by the Company to the Jumana Parties if such breach has not been cured by the end of such notice period; <U>provided</U>
that the Company is not in material breach of this Agreement at the time such notice is given or during the notice period, or (D) the
Jumana Parties or any of their Restricted Persons submits any director nomination for election at any meeting of the Company&rsquo;s stockholders
or (iii) the termination of this Agreement as provided in <U>Section 11</U>. Upon the occurrence of any event described in clause (i)
of this <U>Section 1(j)</U>, the JCP Designee shall promptly offer to resign from the Board (and, if requested by the Company, promptly
deliver his or her written resignation to the Board for his or her immediate resignation), subject to the Board&rsquo;s decision in its
sole discretion whether to accept or reject such resignation; provided, that, in the case of an event described in cause (i)(C) of this
<U>Section 1(j)</U>, if, at the conclusion of the five (5) Business Day period referred to in such clause (i)(C), the parties are not
in agreement that a material breach has occurred, then the JCP Designee&rsquo;s obligation to resign shall be effective only on the tenth
(10th) Business Day following the receipt of the notice referred to in such clause (i)(C). Upon the occurrence of any event described
in clause (ii) of this <U>Section 1(j)</U>, the Jumana Designee shall promptly offer to resign from the Board (and, if requested by the
Company, promptly deliver his or her written resignation to the Board for his or her immediate resignation), subject to the Board&rsquo;s
decision in its sole discretion whether to accept or reject such resignation; provided, that, in the case of an event described in cause
(ii)(C) of this <U>Section 1(j)</U>, if, at the conclusion of the five (5) Business Day period referred to in such clause (ii)(C), the
parties are not in agreement that a material breach has occurred, then the Jumana Designee&rsquo;s obligation to resign shall be effective
only on the tenth (10<SUP>th</SUP>) Business Day following the receipt of the notice referred to in such clause (ii)(C). The Investor
Parties agree to cause, and agree to cause their respective Controlling and Controlled Affiliates to cause, the applicable New Director
(including, for the avoidance of doubt, any Replacement Investor Designees) to resign from the Board if they fail to resign if and when
requested to deliver such resignation pursuant to this <U>Section 1(j)</U>.</P>
<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cooperation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Non-Disparagement</U>.
During the Cooperation Period, the Company and each Investor Party solely for and on behalf of itself shall each refrain from
making, and shall cause its respective Controlling and Controlled Affiliates (and those under common Control) and each of its and
their respective principals, directors, members, managers, general partners, officers and employees (collectively, &ldquo;<B>Covered
Persons</B>&rdquo;) not to make or cause to be made any public written or oral statement, announcement or media placement or
publication (each, a &ldquo;<B>Statement</B>&rdquo;) that constitutes an <I>ad hominem</I> attack on, that otherwise disparages,
defames, impugns, criticizes, or otherwise calls into disrepute, or that is otherwise reasonably likely to cause damage to the
reputation of (A) in the case of any Statement by any of the Investor Parties or their Covered Persons: the Company, any of its
Affiliates or any of its or their respective current or former Covered Persons (solely in their capacities as such); and (B) in the
case of any Statement by the Company or its Covered Persons: any of the Investor Parties, any of their respective Affiliates or any
of their respective current or former Covered Persons (solely in their capacities as such), in each case including (x) in any
statement, document, or report filed with, furnished to, or otherwise provided to the SEC or any other governmental or regulatory
authority, (y) in any press release or other form of public Statement made available to any form of media, and (z) to any journalist
or member of the media (including in a television, radio, newspaper, or magazine interview, podcast or Internet or social media
communication). The foregoing shall not (I) restrict the ability of any Person to comply with any subpoena or other legal process or
respond truthfully to a request for information from any governmental or regulatory authority with jurisdiction over such Person or
to enforce such Person&rsquo;s rights under this Agreement or (II) apply to any private communication among the Investor Parties and
their Affiliates, Covered Persons and Representatives (in their respective capacities as such), on the one hand, and among the
Company and its Affiliates, Covered Persons and Representatives (in their respective capacities as such), on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voting</U>. During the Cooperation Period, each Investor Party will cause all of the Common Stock that such Investor Party or
any of its Controlling or Controlled Affiliates (or those under common Control) has the right to vote (or to direct the vote), as of the
applicable record date, to be present in person or by proxy for quorum purposes and to be voted at any meeting of stockholders of the
Company or at any adjournment or postponement thereof or to deliver any consent or consent revocation, as applicable, in connection with
any action by written consent of the stockholders of the Company in lieu of a meeting, (i) in favor of each director nominated and recommended
by the Board, (ii) against any stockholder nomination for director that is not approved and recommended by the Board for election, (iii)
against any proposal or resolution to remove any member of the Board, and (iv) in accordance with the recommendations by the Board on
all other proposals or business that may be the subject of stockholder action; <U>provided</U>, <U>however</U>, that the Investor Parties
and their Affiliates shall be permitted to vote in their sole discretion on any proposal with respect to any Extraordinary Transaction;
<U>provided</U>, <U>further</U>, that in the event that both Institutional Shareholder Services Inc. and Glass Lewis &amp; Co., LLC (including
any successors thereof) issue a voting recommendation that differs from the voting recommendation of the Board with respect to any proposal
submitted to stockholders at a stockholder meeting (other than with respect to the election of directors to the Board, the removal of
directors from the Board, the size of the Board and/or the filling of any vacancy on the Board), the Investor Parties and their Affiliates
may, but are not required to, vote in accordance with any such recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Standstill</U>. During the Cooperation Period, each Investor Party agrees solely on behalf of itself that it will not, and will
cause its Controlling and Controlled Affiliates (and those under common Control) and its and their respective Representatives acting on
their behalf (collectively with such Investor Parties, the &ldquo;<B>Restricted Persons</B>&rdquo;) to not, directly or indirectly, without
the prior written consent, written invitation, or written authorization of the Company or the Board:</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> acquire, or offer, or agree to acquire, by purchase or otherwise, or direct any Third Party in the acquisition of record or beneficial
ownership of or economic exposure to any Voting Securities or engage in any swap or hedging transaction, or other derivative agreement
of any nature with respect to any Voting Securities, in each case, if such acquisition, offer, agreement or transaction would result in
the Investor Parties, together with their Affiliates, having beneficial ownership of, or a Net Long Position in, more than 20% of the
Common Stock outstanding at such time; <U>provided</U>, that for purposes of the foregoing ownership limitation, it is understood and
agreed that any securities acquired or underlying any award or grant from the Company with respect to a Restricted Person&rsquo;s service
as a director, officer or employee of the Company shall be excluded;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>other than in broker sale transactions where the identity of the purchaser is not known or with the prior approval of the Company
(not to be unreasonably withheld, conditioned or delayed), sell or agree to sell directly or indirectly, through swap or hedging transactions
or otherwise, Common Stock or any derivatives relating to Common Stock to any Third Party that (A) has, to the Investor Parties knowledge,
run (or publicly announced an intention to run) a proxy contest with respect to another company in the past three years, (B) has filed
a Schedule 13D with respect to the Company or any other entity that is publicly traded in the U.S. markets in the past three years, or
(C) if the Investor Parties know, after reasonable inquiry, that such Third Party has, or will as a result of the transaction have, beneficial
ownership of, or a Net Long Position in, more than 4.9% of the Common Stock; <U>provided</U> that, in the case of clauses (B) and (C)
the restriction in this <U>Section 2(c)(ii)</U> shall not apply so long as such Third Party has not disclosed (either publicly or privately
to the Investor Parties) any intention to influence or change the Board or management of the Company or any other change in the Company&rsquo;s
business or corporate structure;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>alone or in concert with any one or more Third Parties, (A) call or seek to call (publicly or otherwise) a meeting of the Company&rsquo;s
stockholders or act by written consent in lieu of a meeting (or call or seek to call for the setting of a record date therefor), (B) seek
election or appointment to, or representation on, the Board or nominate or propose the nomination of, or recommend the nomination of,
any candidate to the Board, except as expressly set forth in <U>Section 1</U>, (C) make or be the proponent of any stockholder proposal
relating to the Company, the Board or any of its committees, (D) seek (including through any &ldquo;withhold&rdquo; or similar campaign)
the removal of any member of the Board, or (E) conduct, call for, or publicly support any other stockholder who conducts or calls for
any referendum of stockholders of the Company; <U>provided</U> that nothing in this Agreement will prevent the Restricted Persons from
(x) taking action in furtherance of identifying any Replacement Investor Designee in accordance with <U>Section 1(e)</U> or (y) stating
how they intend to vote on any matter for which the Investor Parties have voting discretion pursuant to, and in accordance with, <U>Section
2(b)</U>, and the reasons therefor, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make any request for stock list materials or other books and records of the Company or any of its Affiliates under Section&nbsp;220
of the Delaware General Corporation Law or any other statutory or regulatory provision providing for stockholder access to books or records
of the Company or any of its Affiliates;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> engage in, or knowingly assist (it being agreed that statements made in accordance with clause (y) of <U>Section 2(c)(iii)</U>
shall be permitted) in the engagement in, any &ldquo;solicitation&rdquo; (as such term is used in the proxy rules of the SEC, but including,
notwithstanding anything to the contrary in Rule 14a-2 under the Exchange Act, solicitations of ten (10) or fewer stockholders that would
otherwise be excluded from the definition of &ldquo;solicitation&rdquo; pursuant to Rule 14a-2(b)(2) under the Exchange Act) of one or
more proxies or consents with respect to the election or removal of one or more directors of the Company or any other matter or proposal
relating to the Company or become a &ldquo;participant&rdquo; (as such term is defined in Instruction 3 to Item 4 of Schedule 14A under
the Exchange Act) in any such solicitation of proxies or consents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make or submit to the Company or any of its Affiliates any proposal for, or offer of (with or without one or more conditions),
either alone or in concert with others, any tender offer, exchange offer, merger, consolidation, acquisition, sale of all or substantially
all assets, business combination, recapitalization, restructuring, liquidation, dissolution or similar extraordinary transaction involving
the Company (or one or more of its direct or indirect subsidiaries and joint ventures or any of their respective securities or assets)
(each, an &ldquo;<B>Extraordinary Transaction</B>&rdquo;), either publicly or in a manner that would reasonably be expected to require
public disclosure (including in any Schedule 13D) by the Company or any of the Restricted Persons (it being understood that the foregoing
shall not restrict the Restricted Persons from tendering shares, receiving consideration or other payment for shares, or otherwise participating
in any Extraordinary Transaction on the same basis as other stockholders of the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make or submit any proposal, announcement, statement or request in each case either publicly or in a manner that would reasonably
be expected to result in or require any public announcement or public disclosure (including in any Schedule 13D) by the Company or any
Restricted Person, either alone or in concert with others, for or with respect to (A) any change in the number or identity of directors
of the Company or the filling of any vacancy on the Board, except as expressly set forth in <U>Section 1</U>, (B) any change in the capitalization,
capital allocation policy or dividend policy of the Company, or sale, spinoff, splitoff or other similar separation of one or more business
units of the Company, (C) any other change to the Board or the Company&rsquo;s management or corporate or governance structure, except
as expressly set forth in <U>Section 1</U>, (D) any waiver, amendment or modification to the Company&rsquo;s Restated Certificate of Incorporation
(as may be amended from time to time, the &ldquo;<B>Certificate of Incorporation</B>&rdquo;) or Bylaws, (E) causing the Common Stock to
be delisted from, or to cease to be authorized to be quoted on, any securities exchange, or (F) causing the Common Stock to become eligible
for termination of registration pursuant to Section&nbsp;12(g)(4) of the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>knowingly encourage or advise any Third Party or knowingly assist any Third Party in encouraging or advising any other Person with
respect to (A) the giving or withholding of any proxy relating to, or other authority to vote, any Voting Securities, or (B) conducting
any type of referendum relating to the Company (including for the avoidance of doubt with respect to the Company&rsquo;s management or
the Board), other than such encouragement or advice that is consistent with the Board&rsquo;s recommendation in connection with such matter,
or as otherwise expressly permitted by this Agreement (it being understood that
the foregoing shall not prevent any Restricted Person from stating how it intends to vote on any matter for which the Investor Parties
have voting discretion pursuant to, and in accordance with, <U>Section 2(b)</U>, and the reasons therefor);</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>form, join, knowingly encourage (it being agreed that statements made in accordance with clause (y) of <U>Section 2(c)(iii)</U>
shall be permitted), participate or act in concert with any Group with respect to any Voting Securities, other than solely with the Investor
Parties and Affiliates thereof with respect to Voting Securities now or hereafter owned by them;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into any voting trust, arrangement or agreement with respect to any Voting Securities, or subject any Voting Securities to
any voting trust, arrangement or agreement (excluding customary brokerage accounts, margin accounts, prime brokerage accounts and the
like), in each case other than (A) this Agreement, (B) solely between or among any two or more of the Investor Parties and their Affiliates,
(C) granting any proxy in any solicitation approved by the Board and consistent with the recommendation of the Board or (D) granting any
proxy in any solicitation in connection with any matter for which the Investor Parties have voting discretion pursuant to, and in accordance
with, <U>Section 2(b)</U> (it being understood that no proxies shall be granted with the purpose or effect of circumventing the Investor
Parties&rsquo; obligations provided in <U>Section 2(b)</U>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>engage in any short sale or any purchase, sale, or grant of any option, warrant, convertible security, share appreciation right,
or other similar right (including any put or call option or &ldquo;swap&rdquo; transaction) with respect to any security (other than any
index fund, exchange-traded fund, benchmark fund or broad basket of securities) that includes, relates to, or derives any significant
part of its value from a decline in the market price or value of any of the Company&rsquo;s securities and would, in the aggregate or
individually, result in the Investor Parties ceasing to have a Net Long Position in the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>sell, offer or agree to sell, directly or indirectly, through swap or hedging transactions or otherwise, all or substantially all,
voting rights decoupled from the underlying Common Stock held by a Restricted Person to any Third Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>institute, solicit or join as a party any litigation, arbitration or other proceeding (including derivative actions) against or
involving the Company, any of its subsidiaries or any of its or their respective current or former directors or officers (solely in their
capacities as such); <U>provided</U>, <U>however</U>, that for the avoidance of doubt, the foregoing shall not prevent any Investor Party
from (A) bringing litigation against the Company to enforce (x) any provision of this Agreement instituted in accordance with and subject
to <U>Section 9</U> or (y)&nbsp;any provision of the Purchase Agreement instituted in accordance with the terms thereof, (B) making any
counterclaim with respect to any proceeding initiated by, or on behalf of, the Company or its Affiliates against any Restricted Person,
(C) bringing <I>bona fide</I> commercial disputes that do not relate to the subject matter of this Agreement, (D)&nbsp;exercising
statutory appraisal rights, or (E) responding to or complying with validly issued legal process;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into any negotiation, agreement, arrangement, or understanding (whether written or oral) with any Third Party to take any
action that the Restricted Persons are prohibited from taking pursuant to this <U>Section 2(c)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into or maintain any economic, compensatory or pecuniary agreement, arrangement or understanding (written or oral) with any
director of the Company or nominee for director of the Company, in each case, in connection with such individual&rsquo;s service as, or
actions taken in their capacity as, a director of the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left; text-indent: 1.5in">(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make any request or submit any proposal to amend or waive any of the terms of this Agreement (including this subclause), in each
case publicly or that would reasonably be expected to result in or require any public announcement or disclosure (including in any Schedule
13D) by the Company or any Restricted Person of such request or proposal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in"><U>provided</U> that the
restrictions in this <U>Section 2(c)</U> shall terminate automatically upon the earliest of the following: (A) any material breach
of this Agreement by the Company (including any failure to appoint the New Directors to the Board in accordance with <U>Section
1(a)</U>, to include the New Directors in the slate of nominees recommended by the Board in the Company&rsquo;s proxy statement and
on its proxy card relating to any annual meeting of stockholders held during the Cooperation Period in accordance with <U>Section
1(</U>c), or to issue the Press Release in accordance with <U>Section 3</U>) upon five (5) Business Days&rsquo; written notice by
any of the Investor Parties to the Company if such breach has not been cured within such notice period; <U>provided</U> that the
Investor Parties are not in material breach of this Agreement at the time such notice is given or prior to the end of the notice
period; (B) the Company&rsquo;s entry into (x) a definitive agreement with respect to any Extraordinary Transaction that would
result in the acquisition by any Person or Group of more than 50% of the Voting Securities or assets having an aggregate value
exceeding 50% of the aggregate enterprise value of the Company, (y) one or more definitive agreements providing for a transaction or
series of related transactions which would in the aggregate result in the Company issuing to one or more Third Parties at least 20%
of the Common Stock (including on an as-converted basis, and including other Voting Securities with comparable voting power)
outstanding immediately prior to such issuance(s) (including in a PIPE, convertible note, convertible preferred security or similar
structure) during the Cooperation Period (provided that securities issued as consideration for (or in connection with) the
acquisition of the assets, securities or business(es) of another Person by the Company or one or more of its subsidiaries shall not
be counted toward this clause (y)); and (C) the commencement of any tender or exchange offer (by any Person or Group other than the
Investor Parties or their Affiliates) which, if consummated, would constitute an Extraordinary Transaction that would result in the
acquisition by any Person or Group of more than 50% of the Voting Securities, where the Company files with the SEC a Schedule 14D-9
(or amendment thereto) that does not recommend that its stockholders reject such tender or exchange offer (it being understood that
nothing herein will prevent the Company from issuing a &ldquo;stop, look and listen&rdquo; communication pursuant to Rule 14d-9(f)
promulgated by the SEC under the Exchange Act in response to the commencement of any tender or exchange offer). Notwithstanding
anything to the contrary in this Agreement, nothing
in this Agreement (including the restrictions in this <U>Section 2(c)</U>) will prohibit or restrict any Restricted Person from (I) making
any public or private statement or announcement with respect to an Extraordinary Transaction that is publicly announced by the Company,
(II) making any factual statement to comply with any subpoena or other legal process or respond to a request for information from any
governmental authority with jurisdiction over such Restricted Person from whom such information is sought (so long as such process or
request did not arise as a result of any discretionary act by any Restricted Person); </P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><U>provided</U> that such Restricted Person will
notify the Company promptly in writing (if reasonably practicable and to the extent legally permitted) of the existence, terms, and circumstances
surrounding such request or requirement; <U>provided</U>, <U>further</U>, that, no Restricted Person shall be required to provide the
notice to the Company referenced in the immediately preceding proviso in the case of disclosures required to be made by such Restricted
Person in the course of a routine audit or review by a competent regulatory or administrative authority which is not specifically related
to the Company or such Restricted Person&rsquo;s interactions with the Company, (III) granting any lien or encumbrance on any claim or
interest in favor of a bank or broker-dealer or prime broker holding such claim or interest in custody or prime brokerage in the ordinary
course of business, which lien or encumbrance is released upon the transfer of such claim or interest in accordance with the terms of
the custody or prime brokerage agreement(s), as applicable, (IV) negotiating, evaluating or trading, directly or indirectly, in any index
fund, exchange-traded fund, benchmark fund or broad basket of securities that may contain or otherwise reflect the performance of, but
does not primarily consist of, securities of the Company or (V) providing its views privately to any members of the Board, the Company&rsquo;s
Chief Executive Officer, Chief Financial Officer, or Chief Legal Officer or any member of the Company&rsquo;s investor relations team
or advisors that have been identified by one of the foregoing to the Investor Parties as appropriate contacts (each, a &ldquo;<B>Contact
Person</B>&rdquo;) regarding any matter, or privately requesting a waiver of any provision of this Agreement, so long as such private
communications or requests would not reasonably be expected to result in or require any public announcement or public disclosure (including
on any Schedule 13D) of such communications or requests by the Company or any of the Restricted Persons. Each of the Investor Parties
acknowledge and agree that any discussions between any Contact Person and any Restricted Persons will be subject to, and shall be conducted
in accordance with, applicable law, such Contact Person&rsquo;s fiduciary duties to the Company, such Contact Person&rsquo;s confidentiality
obligations to the Company and such Contact Person&rsquo;s other obligations pursuant to the terms of the applicable Company Policies.
Furthermore, nothing in this Agreement shall prohibit or restrict any New Director from exercising his or her rights and fiduciary duties
as a director of the Company or any committee member of the Board or restrict his or her discussions solely among other members of the
Board, any committee, management, advisors, Representatives or agents of the Company; <U>provided</U> that any such discussions are limited
to communications in his or her capacity as a director or committee member, as applicable and recognizing such actions are subject to
such New Director&rsquo;s fiduciary duties to the Company and its stockholders and the Company Policies.</P>




<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Public Announcement.</U> Unless otherwise agreed in writing by the Company and the Investor Parties, not later than 9:00 a.m.
Eastern Time on the first Business Day after the Effective Date, the Company shall issue a press release (the &ldquo;<B>Press Release</B>&rdquo;)
in the form of Exhibit C, and thereafter shall promptly file with the SEC a Current Report on Form 8-K (the &ldquo;<B>Form 8-K</B>&rdquo;)
disclosing its entry into this Agreement and including a copy of this Agreement and the Press Release as exhibits thereto. The Investor
Parties shall promptly, but in no case prior to the issuance of the Press Release or the filing
of the Form 8-K with the SEC (except to the extent necessary for the Investor Parties to comply with their obligations under applicable
securities law), file an amendment to the Schedule 13D (the &ldquo;<B>13D Amendment</B>&rdquo;) with respect to the Company originally
filed by the Investor Parties and the other filing persons reporting thereon with the SEC on October 9, 2024, reporting the entry into
this Agreement, including a copy of this Agreement and amending, restating, supplementing or otherwise modifying all applicable items
to conform to its obligations hereunder. The Form 8-K and the 13D Amendment shall each be consistent with the Press Release and the terms
of this Agreement, and shall be in form and substance reasonably acceptable to the Company and the Investor Parties. The Company shall
provide the Investor Parties with a copy of the Form 8-K prior to filing with the SEC and shall consider any reasonable and timely comments
of the Investor Parties and their Representatives. The Investor Parties shall provide the Company and its Representatives with a copy
of the 13D Amendment prior to its filing with the SEC and shall consider any timely comments of the Company and its Representatives. Neither
the Company or any of its Affiliates nor the Investor Parties or any of their Affiliates shall make any public statement (or other communication
reasonably expected to become or result in a public disclosure) regarding the subject matter of this Agreement, this Agreement or the
matters set forth in the Press Release prior to the issuance of the Press Release without the prior written consent of the other party
and no party shall make any statements inconsistent with the Press Release in connection with the announcement of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties of the Company</U>. The Company represents and warrants that: (a) the Company has the power and
authority to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated
by this Agreement; (b) this Agreement has been duly and validly authorized, executed, and delivered by the Company, constitutes a valid
and binding obligation and agreement of the Company and, assuming the valid execution and delivery hereof by each of the other parties,
is enforceable against the Company in accordance with its terms, except as enforcement of this Agreement may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or similar laws generally affecting the rights of creditors
and subject to general equity principles; and (c) the execution, delivery and performance of this Agreement by the Company does not and
will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to the Company, or (ii) result in
any breach or violation of or constitute a default (or an event that, with notice or lapse of time or both, could constitute a breach,
violation or default) under or pursuant to, result in the loss of a material benefit under, or give any right of termination, amendment,
acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which the
Company is a party or by which it is bound.</P>




<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties of the Investor Parties</U>. Each Investor Party, severally and not jointly, represents and warrants
that: (a) such Investor Party has the power and authority to execute, deliver and carry out the terms and provisions of this Agreement
and to consummate the transactions contemplated by this Agreement; (b) this Agreement has been duly and validly authorized, executed and
delivered by such Investor Party, constitutes a valid and binding obligation and agreement of such Investor Party and, assuming the valid
execution and delivery hereof by each of the other parties, is enforceable against such Investor Party in accordance with its terms, except
as enforcement of this Agreement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance
or similar laws generally affecting the rights of creditors
and subject to general equity principles; (c) the execution, delivery and performance of this Agreement by such Investor Party does not
and will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to such Investor Party, or (ii)
result in any breach or violation of or constitute a default (or an event that, with notice or lapse of time or both, could constitute
a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination,
amendment, acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement
to which such Investor Party is a party or by which it is bound; and (d) without giving effect to the issuance of Common Stock pursuant
to the Purchase Agreement, such Investor Party (x) beneficially owns (as defined in Rule 13d-3 under the Exchange Act) the amount set
forth next to its name on Exhibit A or Exhibit B, as applicable and (y) has a Net Long Position in, or aggregate economic exposure to,
the amount of Common Stock set forth next to its name on Exhibit A or Exhibit B, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definitions</U>. For purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Affiliate</B>&rdquo; has the meaning set forth in Rule 12b-2 under the Exchange Act and shall include any Person
who otherwise qualifies as an Affiliate at any time subsequent to the date of this Agreement; <U>provided</U> that none of the Company
or its Affiliates or Representatives, on the one hand, and the Investor Parties and their Affiliates or Representatives, on the other
hand, shall be deemed to be &ldquo;<B>Affiliates</B>&rdquo; with respect to the other for purposes of this Agreement; <U>provided</U>,
<U>further</U>, that &ldquo;<B>Affiliates</B>&rdquo; of a Person shall not include any entity solely by reason of the fact that one or
more of such Person&rsquo;s employees or principals serves as a member of such entity&rsquo;s board of directors or similar governing
body, unless such Person otherwise Controls such entity; <U>provided</U>, <U>further</U>, that, with respect to the Investor Parties,
&ldquo;<B>Affiliates</B>&rdquo; shall not include any portfolio operating company (as such term is understood in the private equity industry)
of any Investor Party or their Affiliates (unless such portfolio operating company is controlled by, or acting on behalf of or at the
direction of, any of the Investor Parties or their Affiliates to engage in conduct prohibited by this Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the terms &ldquo;<B>beneficial owner</B>,&rdquo; &ldquo;<B>beneficially own</B>,&rdquo; and &ldquo;<B>beneficial ownership</B>&rdquo;
have the meanings set forth in Rule 13d-3 and Rule 13d-5(b)(1) under the Exchange Act, except that a Person will also be deemed to be
the beneficial owner of all shares of the Company&rsquo;s capital stock that (i) such Person has the right to acquire (whether such right
is exercisable immediately or only after the passage of time) pursuant to the exercise of any right in connection with any securities
or any agreement, arrangement or understanding (whether or not in writing), regardless of when such rights may be exercised and whether
they are conditional, and (ii) such Person or any of such Person&rsquo;s Affiliates has or shares the right to vote or dispose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Business Day</B>&rdquo; means any day other than a Saturday, a Sunday, a legal holiday in Englewood, Colorado,
or a day on which the Federal Reserve Bank of New York is closed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Bylaws</B>&rdquo; means the Company&rsquo;s Fifth Amended and Restated Bylaws (as amended or restated from time
to time);</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the term &ldquo;<B>Common Stock</B>&rdquo; means the Company&rsquo;s common stock, par value $0.001 per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Control</B>&rdquo; (including the terms &ldquo;Controlling,&rdquo; &ldquo;Controlled,&rdquo; and &ldquo;under
common Control&rdquo;) mean the possession, direct or indirect, of the power to direct or cause the direction of the management and policies
of a Person, whether through the ownership of Voting Securities, by contract, or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Cooperation Period</B>&rdquo; means the period commencing on the Effective Date and concluding on the date that
is the earlier of (1) thirty (30) calendar days prior to the advance notice deadline set forth in the Bylaws for the stockholder nomination
of non-proxy access director candidates for election to the Board at the Company&rsquo;s Annual Meeting of Stockholders during the Company&rsquo;s
fiscal year 2026 (the <B>&ldquo;2026 Annual Meeting</B>&rdquo;) and (2) one hundred twenty (120) calendar days prior to the first anniversary
of the 2025 Annual Meeting (collectively, the &ldquo;<B>2026 Advance Notice Window</B>&rdquo;); <U>provided</U>, <U>however</U>, that
the conclusion of the Cooperation Period shall be extended and delayed until the date that is the earlier of (x) thirty (30) calendar
days prior to the advance notice deadline set forth in the Bylaws for the stockholder nomination of non-proxy access director candidates
for election to the Board at the Company&rsquo;s Annual Meeting of Stockholders during the Company&rsquo;s fiscal year 2027 and (y) one
hundred twenty (120) calendar days prior to the first anniversary of the 2026 Annual Meeting if (A) the Company determines to and irrevocably
offers to re-nominate the New Directors for election at the 2026 Annual Meeting; <U>provided</U> that the Company notifies the New Directors
in writing at least fifteen (15) calendar days prior to the opening of the 2026 Advance Notice Window of such determination and offers
to irrevocably re-nominate the New Directors for election at the 2026 Annual Meeting, and (B) the New Directors agree to such nomination
within fifteen (15) calendar days of receipt of such notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Exchange Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated by the SEC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Group</B>&rdquo; has the meaning set forth in Section&nbsp;13(d)(3) of the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Net Long Position</B>&rdquo; means, with respect to any Person, such Person&rsquo;s &ldquo;net long position&rdquo;
as defined in Rule 14e-4 under the Exchange Act, in respect of the Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the terms &ldquo;<B>Person</B>&rdquo; or &ldquo;<B>Persons</B>&rdquo; shall be interpreted broadly to include any individual, corporation
(including not-for-profit), general or limited partnership, limited liability or unlimited liability company, joint venture, estate, trust,
association, organization or other entity of any kind or nature;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Qualified Director</B>&rdquo; means an individual who (i) qualifies as independent of the Company under all
applicable listing standards, applicable rules of the SEC and publicly disclosed standards used by the Board in determining the independence
of the Company&rsquo;s directors, (ii) meets all other qualifications required for service as a director set forth in the Bylaws and other
Company Policies as of the Effective Date that are applicable to other non-management directors and (iii) has the
relevant financial and business experience to be a director of the Company;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Representatives</B>&rdquo; means a party&rsquo;s directors, principals, members, general partners, trustees,
managers, officers, employees, agents, advisors and other representatives;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>SEC</B>&rdquo; means the U.S. Securities and Exchange Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Third Party</B>&rdquo; means any Person that is not a party to this Agreement or an Affiliate thereof, a director
or officer of the Company, or legal counsel to any party to this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the term &ldquo;<B>Voting Securities</B>&rdquo; means the Common Stock and any other Company securities entitled to vote in the
election of directors, or securities convertible into, or exercisable or exchangeable for, such shares or other securities, whether or
not subject to the passage of time or other contingencies; <U>provided</U> that, as pertains to any obligation of the Investor Parties
or any other Restricted Person (including under <U>Section 2(c)</U>), &ldquo;Voting Securities&rdquo; will not include any securities
contained in any index fund, exchange-traded fund, benchmark fund or broad basket of securities that may contain or otherwise reflect
the performance of, but does not primarily consist of, securities or other interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. All notices, consents, requests, instructions, approvals and other communications provided for herein, and all
legal process in regard hereto, will be in writing and will be deemed validly given, made or served when delivered in person, by electronic
mail, by overnight courier, or two Business Days after being sent by registered or certified mail (postage prepaid, return receipt requested)
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Red Robin Gourmet Burgers, Inc.<BR>
10000 E. Geddes Avenue, Suite 500<BR>
Englewood, Colorado 80112<BR>
Attention: Sarah Mussetter, Chief Legal Officer<BR>
Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"><FONT STYLE="color: #231F20">Paul, Weiss, Rifkind, Wharton
&amp; Garrison LLP<BR>
1285 Avenue of the Americas<BR>
New York, NY 10019-6064<BR>
Attention: Scott A. Barshay and Kyle</FONT> T. Seifried<BR>
Email: sbarshay@paulweiss.com / kseifried@paulweiss.com</P>




<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">If to the JCP Parties:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">JCP Investment Management, LLC<BR>
1177 West Loop South, Suite 1320<BR>
Houston, Texas 77027<BR>
Attention: James C. Pappas<BR>
Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Olshan Frome Wolosky LLP<BR>
1325 Avenue of the Americas<BR>
New York, New York 10019<BR>
Attention: Ryan Nebel and Rebecca Van Derlaske<BR>
Email: RNebel@olshanlaw.com / RVanDerlaske@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">If to the Jumana Parties:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Jumana Capital Investments LLC<BR>
1717 Saint James Place, Suite 335<BR>
Houston, Texas 77056<BR>
Attention: Christopher Martin<BR>
Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Olshan Frome Wolosky LLP<BR>
1325 Avenue of the Americas<BR>
New York, New York 10019<BR>
Attention: Ryan Nebel and Rebecca Van Derlaske<BR>
Email: RNebel@olshanlaw.com / RVanDerlaske@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">At any time, any party may, by notice given
in accordance with this <U>Section 7</U> to the other party, provide updated information for notices under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expenses</U>. All fees, costs and expenses incurred in connection with this Agreement and all matters related to this Agreement
will be paid by the party incurring such fees, costs or expenses; <U>provided</U>, <U>however</U>, that the Company shall promptly reimburse
the Investor Parties for their reasonable and documented out-of-pocket fees and expenses incurred through the date hereof in connection
with the Investor Parties&rsquo; investment in the Company, the negotiation and execution of this Agreement and the Purchase Agreement,
and the subject matters thereof and the transactions contemplated thereby, <U>provided</U> that such reimbursement shall not exceed $185,000
in the aggregate. The Company shall remit such reimbursement to the Investor Parties within five (5) Business Days of receiving the proper
documentation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Specific Performance; Remedies; Venue; Waiver of Jury Trial</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and each Investor Party acknowledge and agree that irreparable injury to the other party would occur in the event any
of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">and that such injury would not be adequately
compensable by the remedies available at law (including the payment of money damages). It is accordingly agreed that the Company, on the
one hand, and the Investor Parties (acting jointly or severally), on the other hand, will be entitled to seek an injunction or injunctions
to prevent breaches of this Agreement and to seek to enforce specifically the terms and provisions of this Agreement, in addition to any
other remedy to which they are entitled at law or in equity. FURTHERMORE, THE COMPANY AND EACH INVESTOR PARTY AGREES: (1) THE NON-BREACHING
PARTY WILL BE ENTITLED TO INJUNCTIVE AND OTHER EQUITABLE RELIEF, WITHOUT PROOF OF ACTUAL DAMAGES; (2) THE BREACHING PARTY WILL NOT PLEAD
IN DEFENSE THERETO THAT THERE WOULD BE AN ADEQUATE REMEDY AT LAW; AND (3) THE BREACHING PARTY AGREES TO WAIVE THE POSTING OF A BOND OR
OTHER SECURITY OR BONDING REQUIREMENT UNDER ANY APPLICABLE LAW, IN THE CASE THAT ANY OTHER PARTY SEEKS TO ENFORCE THE TERMS BY WAY OF
EQUITABLE RELIEF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Agreement will be governed in all respects, including validity, interpretation, and effect, by the laws of the State of Delaware
without giving effect to the choice of law principles of such state. The Company and each Investor Party (i) irrevocably and unconditionally
submits to the exclusive jurisdiction of the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept
jurisdiction over a particular matter, the federal or other state courts located in Wilmington, Delaware), (ii) agrees that it will not
attempt to deny or defeat such jurisdiction by motion or other request for leave from any such court, (iii) agrees that any action or
proceeding based on, relating to, or arising in connection with this Agreement or the transactions contemplated by this Agreement shall
be brought, tried, and determined only in such courts, (iv) waives any claim of improper venue or any claim that those courts are an inconvenient
forum, and (v) agrees that it will not bring any action based on, relating to, or arising in connection with this Agreement or the transactions
contemplated by this Agreement in any court other than such courts. The parties to this Agreement agree that the delivery of process in
connection with any such action or proceeding in the manner provided in <U>Section 7</U> or in such other manner as may be permitted by
applicable law as sufficient service of process, shall be valid and sufficient service thereof; <U>provided</U> that such process or other
papers based on, relating to, or arising in connection with any such action or proceeding is also substantially contemporaneously delivered
to the email address of such party set forth in <U>Section 7</U> (for the avoidance of doubt, such email shall not in and of itself constitute
effective service of process).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>EACH OF THE PARTIES, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY
WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LITIGATION BASED ON, RELATING TO OR ARISING IN CONNECTION WITH THIS
AGREEMENT OR ANY RELATED INSTRUMENT OR AGREEMENT, OR ANY OF THE TRANSACTIONS CONTEMPLATED THEREBY, OR ANY COURSE OF CONDUCT, DEALING,
STATEMENTS (WHETHER ORAL OR WRITTEN), OR ACTIONS OF ANY OF THEM. NO PARTY SHALL SEEK TO CONSOLIDATE, BY COUNTERCLAIM OR OTHERWISE, ANY
ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If, at any time subsequent to the Effective Date, any provision of this Agreement is held by any court of
competent jurisdiction to be illegal, void or unenforceable, such provision will be of no force and effect, but the illegality, voidness
or unenforceability of such provision will have no effect upon the legality or enforceability of any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination</U>. This Agreement will terminate upon the expiration of the Cooperation Period. Upon such termination, this Agreement
shall have no further force and effect. Notwithstanding the foregoing, <U>Sections 7</U> to <U>16</U> shall survive termination of this
Agreement, and no termination of this Agreement shall relieve any party of liability for any breach of this Agreement arising prior to
such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but both
or all of which shall constitute the same agreement. Signatures to this Agreement transmitted by electronic mail in &ldquo;portable document
format&rdquo; (.pdf) form or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document,
will have the same effect as physical delivery of the paper document bearing the original signature. For the avoidance of doubt, no party
shall be bound by any contractual obligation to the other parties until all counterparts to this Agreement have been duly executed by
each of the parties and delivered to the other parties (including by means of electronic delivery).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Third-Party Beneficiary</U>. This Agreement is solely for the benefit of the Company and the Investor Parties and is not
enforceable by any other Person. No party to this Agreement may assign its rights or delegate its obligations under this Agreement, whether
by operation of law or otherwise, without the prior written consent of the other parties in their respective sole discretions, and any
assignment in contravention hereof will be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Waiver</U>. No failure or delay by any party in exercising any right or remedy under this Agreement will operate as a waiver
thereof or of any breach of any provision hereof, nor will any single or partial waiver thereof preclude any other or further exercise
thereof or the exercise of any other right or remedy under this Agreement. The failure of a party to insist upon strict adherence to any
term of this Agreement on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist
upon strict adherence to that term or any other term of this Agreement. No waiver shall be effective unless in writing, executed by the
waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Understanding; Amendment</U>. This Agreement and the Purchase Agreement contain the entire understanding of the parties
with respect to the subject matter hereof and supersede any and all prior and contemporaneous agreements, memoranda, arrangements, and
understandings, whether written or oral, between the parties, or any of them, with respect to the subject matter of this Agreement and
the Purchase Agreement. This Agreement may be amended only by an agreement in writing executed by the Company and the Investor Parties.</P>




<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">Section 16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interpretation and Construction</U>. The Company and each Investor Party acknowledges that it has been represented by counsel
of its choice throughout all negotiations that have preceded the execution of this Agreement, and that it has executed the same after
having had an adequate opportunity to seek the advice
of said counsel. Each party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents
referred to herein, and any and all drafts relating thereto exchanged among the parties will be deemed the work product of all of the
parties and may not be construed against any party by reason of its drafting or preparation. Accordingly, any rule of law or any legal
decision that would require interpretation of any ambiguity in this Agreement against any party that drafted or prepared it is of no application
and is hereby expressly waived by the Company and each Investor Party, and any controversy over any interpretation of this Agreement will
be decided without regard to events of drafting or preparation. Whenever the words &ldquo;include,&rdquo; &ldquo;includes,&rdquo; or &ldquo;including&rdquo;
are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation.&rdquo; When a reference is made
in this Agreement to any Section, such reference shall be to a Section&nbsp;of this Agreement, unless otherwise expressly indicated. The
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of
this Agreement. The words &ldquo;hereof,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereto,&rdquo; and &ldquo;hereunder&rdquo; and words of similar
import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The
word &ldquo;will&rdquo; shall be construed to have the same meaning as the word &ldquo;shall.&rdquo; The word &ldquo;or&rdquo; is not
exclusive. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms. Any agreement,
instrument, law, rule or statute defined or referred to herein means, unless otherwise indicated, such agreement, instrument, law, rule
or statute as from time to time amended, modified or supplemented, except that references to specified rules promulgated by the SEC shall
be deemed to refer to such rules in effect as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[<I>Signature pages follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">IN WITNESS WHEREOF, this
Agreement has been duly executed and delivered by the duly authorized signatories of the parties as of the date hereof.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>INVESTOR PARTIES</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">By: </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Cooperation Agreement</I>]</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>RED ROBIN GOURMET BURGERS, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Cooperation Agreement</I>]</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Exhibit A
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Exhibit B
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 24; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Exhibit C<BR>
<U>Form of Press Release</U></B></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>RED
ROBIN GOURMET BURGERS, INC. ANNOUNCES&nbsp;INVESTMENT AND APPOINTS NEW&nbsp;INDEPENDENT DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>JCP
Investment Management, LLC and Jumana&nbsp;Capital, LLC&nbsp;Invest An Additional $8.3 Million to Pay Down Debt and Support Strategy,
Demonstrating&nbsp;Long-term Commitment to Brand</I></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>James
C. Pappas and Christopher Martin added to Board&nbsp;of Directors</I></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Enters
into Agreement with JCP Investment Management, LLC&nbsp;and&nbsp;Jumana&nbsp;Capital, LLC</I></FONT></P>

<P STYLE="font: 10pt MS PGothic,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20; background-color: white">ENGLEWOOD,
Colo.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">, <FONT STYLE="color: #231F20">December&nbsp;3,
2024 </FONT>--&nbsp;Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) (&ldquo;Red Robin&rdquo; or the &ldquo;Company&rdquo;), a full-service
restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly atmosphere, today announced that
affiliates of JCP Investment Management, LLC (&ldquo;JCP&rdquo;) and Jumana Capital, LLC (&ldquo;Jumana&rdquo;) invested&nbsp;an additional&nbsp;$8.3
million&nbsp;into the Company, strengthening&nbsp;its&nbsp;balance sheet and demonstrating their long-term commitment to the strategy
and brand. &nbsp;Additionally, the Company announced the appointment of&nbsp;James C. Pappas and Christopher Martin to its Board of Directors
(the &ldquo;Board&rdquo;), pursuant to a cooperation agreement (the &ldquo;Agreement&rdquo;) with JCP and Jumana&nbsp;(the &ldquo;Investor
Parties&rdquo;). </FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
Mr. Pappas&rsquo; and Mr. Martin&rsquo;s respective appointments, the Board will expand to 10 directors,&nbsp;nine&nbsp;of whom&nbsp;will
be&nbsp;independent. &nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;JCP&rsquo;s
and Jumana&rsquo;s additional investments demonstrate their commitment and belief in the future of Red Robin,&rdquo;&nbsp;said David
A. Pace, Chairman of the Board. &nbsp;&nbsp;&ldquo;We are pleased to welcome&nbsp;James and Chris&nbsp;to Red Robin&rsquo;s Board of
Directors and look forward to their contributions and expertise as we continue to&nbsp;execute on our strategy for the comeback of this
beloved brand.&nbsp;James&nbsp;brings significant experience in board roles at restaurant brands in similar phases of revitalization
and&nbsp;Chris&nbsp;adds&nbsp;both industry and financial expertise that will be important to our progress.&rdquo;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Agreement,&nbsp;Mr. Pappas and Mr. Martin will be nominated by the Board to stand for election for a full term at the Company&rsquo;s
2025 Annual Meeting of Stockholders.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Pappas stated on behalf of the Investor Parties: &ldquo;We appreciate the dialogue we have had with Red Robin and are supportive of the
Company&rsquo;s strategy and management team.&nbsp; From day one, our focus will be to help decrease debt through our investment proceeds,
increased operating cash flow and the thoughtful exploration and consideration of other debt reduction options available, including the
potential for selective franchising of some company-operated stores.&nbsp; Strengthening the balance sheet positions
Red Robin to continue to deliver fantastic and craveable burgers every day while also building long-term shareholder value.&rdquo;</FONT></P>



<!-- Field: Page; Sequence: 25; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Additionally,
the Company entered into an equity purchase agreement with certain affiliates of the Investor Parties pursuant to which the Company agreed
to issue and sell to them an aggregate of&nbsp;1,600,909 shares of the Company&rsquo;s common stock, at a purchase price of $5.19 per
share, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursuant to a private placement (the &ldquo;Private
Placement&rdquo;) that is exempt from registration under the Securities Act of 1933, as amended<FONT STYLE="background-color: white">.&nbsp;The
aggregate gross proceeds from the Private Placement are expected to be approximately $8.3 million. The net proceeds from the Private
Placement will be used to repay indebtedness and for general corporate expenses. </FONT></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
information on the Agreement and the Private Placement can be found in the Company&rsquo;s Form 8-K filed today with the Securities and
Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
James C. Pappas </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Pappas founded JCP Investment Management in Houston in June 2009 and is the Managing Member and owner of the firm. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
has served as a director of United Natural Foods, Inc. (NYSE: UNFI), a food distributor to grocery stores, since September 2023. Additionally,
<FONT STYLE="background-color: white">he has been the chairman of the board of directors of Innovative Food Holdings, Inc. (OTCQB: IVFH),
a direct-to-chef and restaurant specialty food platform, since 2023, and a director since 2020. Mr. Pappas is also a director of Tandy
Leather Factory, Inc. (NASDAQ: TLF), a specialty retailer and wholesale distributor of leather and leather related products, a position
he has held since 2016. Mr. Pappas previously served on the boards of several other public companies, including food-related businesses
such as Jamba, Inc., The Pantry, Inc., and Morgan&rsquo;s Foods, Inc., as well as </FONT>U.S. Geothermal Inc<FONT STYLE="background-color: white">.
From 2007 until 2009, he was a private investor, in addition to consulting with several businesses. From 2005 until 2007, he worked in
the Investment Banking/Leveraged Finance Division of Goldman Sachs, where he advised private equity groups and corporations on appropriate
leveraged buyout, recapitalization and refinancing alternatives. Prior to that, he was an investment banker at Banc of America Securities,
where he focused on consumer and retail investment banking. He currently also serves as Secretary for the Endowment Advisory Board of
the Annunciation Greek Orthodox Church in Houston and on the Methodist Hospital Gastro Division&rsquo;s Advisory Board in Houston. </FONT>Mr.
Pappas received a BBA in Information Technology, and a Master of Finance from Texas A&amp;M University.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt F1; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Christopher Martin</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Martin has served as a Managing Director of Jumana Capital, LLC, a private investment firm specializing in concentrated investments in
middle market companies, since July 2020, where he is responsible for investment strategy and execution across the portfolio, and serves
as the Manager of Jumana Capital Investments LLC, an affiliated investment entity. Previously, Mr. Martin served as a Vice President
at Hastings Equity Partners, LLC, a private equity firm, from July 2017 until July 2020. Mr. Martin also previously served as the Chief
Financial Officer of Specialty Welding &amp; Turnarounds, LLC, an industrial services company, from October 2017 through January 2020.
Prior to that, Mr. Martin was a Vice President at Simmons &amp; Company International, part of the Piper Sandler Companies (NYSE: PIPR),
from July 2013 to July 2017. Mr. Martin began his career at FTI Consulting, Inc. (NYSE: FCN), a global advisory
firm, in the Corporate Finance and Restructuring group. Mr. Martin holds an MBA from the University of Texas at Austin and a BBA from
Texas Christian University.</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Red
Robin Gourmet Burgers, Inc. (NASDAQ: RRGB)</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Red
Robin Gourmet Burgers, Inc. (<FONT STYLE="color: darkred">www.redrobin.com</FONT>), is a casual dining restaurant chain founded in 1969
that operates through its wholly-owned subsidiary, Red Robin International, Inc., and under the trade name, Red Robin Gourmet Burgers
and Brews. We believe nothing brings people together like burgers and fun around our table, and no one makes moments of connection over
craveable food more memorable than Red Robin. We serve a variety of burgers and mainstream favorites to Guests of all ages in a casual,
playful atmosphere. In addition to our many burger offerings, Red Robin serves a wide array of salads, appetizers, entrees, desserts,
signature beverages and Donatos&reg; pizza at select locations. It's now easy to enjoy Red Robin anywhere with online ordering available
for to-go, delivery and catering, or you can download our new app for easy customization, access to the Red Robin Royalty&reg; dashboard
and more. There are approximately 500 Red Robin restaurants across the United States and Canada, including those operating under franchise
agreements. Red Robin&hellip; YUMMM&reg;!</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements in this press release regarding our future operating or financial performance, our strategy and ability to execute and drive
long term shareholder value, the expected activities in connection with the Investor Parties, and all other statements that are not historical
facts are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on
assumptions believed by the Company to be reasonable and speak only as of the date on which such statements are made. Without limiting
the generality of the foregoing, words such as &ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo;
&ldquo;project,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;outlook&rdquo; or &ldquo;estimate,&rdquo; or the negative
or other variations thereof or comparable terminology are intended to identify forward-looking statements. Except as required by law,
the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date and cautions
investors not to place undue reliance on any such forward-looking statements. Forward-looking statements are subject to various risks
and uncertainties that could cause actual results to differ materially from those cautionary statements and risk factors described from
time to time in the Company&rsquo;s Form 10-K, Form 10-Q, and Form 8-K reports (including all amendments to those reports) filed with the U.S.
Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contacts:
</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
media relations questions:</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kathleen
Bush, Red Robin Gourmet Burgers, Inc.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>kbush@redrobin.com</U></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(303)
846-5114</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liz
DiTrapano, ICR</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Liz.DiTrapano@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(203)
682-4716</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
investor relations questions:</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
Priester, ICR</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jeff.Priester@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(332)
242-4370</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>eh240546757_ex1002.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT 10.2</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; text-align: center">PURCHASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: left; text-indent: 0.5in">This PURCHASE AGREEMENT (this
&ldquo;<U>Purchase Agreement</U>&rdquo;, and the transactions contemplated hereby, the &ldquo;<U>Investment</U>&rdquo;) is entered into
on December 3, 2024 by and between Red Robin Gourmet Burgers, Inc., a Delaware corporation (the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none"><U>Company</U></FONT>&rdquo;),
and the investors listed on the signature pages hereto (the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none"><U>Investors</U></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, concurrently herewith,
the Company and the Investors are entering into that certain Cooperation Agreement, dated as of even date herewith (the &ldquo;<U>Cooperation
Agreement</U>&rdquo;), pursuant to which, among other things, two new independent directors designated by the Investors will be appointed
to the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, in furtherance thereof,
the Investors have agreed to purchase shares of the Company&rsquo;s common stock, par value $0.001 per share (&ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none"><U>Common
Stock</U></FONT>&rdquo;), in a private placement for a purchase price of $5.19 per share of Common Stock (the &ldquo;<U>Per Share Purchase
Price</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, the aggregate purchase
price to be paid by the Investors for the aggregate number of shares of Common Stock to be purchased by the Investors (the &ldquo;<U>Purchased
Securities</U>&rdquo;) (as set forth on the signature pages hereto) is referred to herein as the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none"><U>Purchase
Price</U></FONT>&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, at least $7.0 million
of the net proceeds of the Investment will be used by the Company to repay indebtedness; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">WHEREAS, the Board has unanimously
(a) approved, adopted and declared advisable this Purchase Agreement and the Investment, (b) declared that it is in the best interests
of the Company and the stockholders of the Company that the Company enter into this Purchase Agreement and consummate the Investment and
(c) exempted this Purchase Agreement, the Investment, the Cooperation Agreement and the transactions contemplated hereby and thereby from
the provisions of Section 203 of the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein, and intending
to be legally bound hereby, each of the Investors and the Company acknowledges and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Purchase</U>. The Investors hereby irrevocably agree, severally and not jointly, to purchase at the Closing (as defined below)
from the Company, and the Company hereby agrees to issue and sell to the Investors at the Closing, severally and not jointly, the number
of Purchased Securities set forth the respective signature pages of this Purchase Agreement at the Purchase Price, on the terms and subject
to the conditions provided for herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 40.5pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The closing of the purchase and sale of the Purchased Securities contemplated hereby (the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Closing</U></FONT>&rdquo;)
shall take place at 9:00 a.m., New York City time, on the date hereof (the &ldquo;<U>Closing Date</U>&rdquo;), at the offices of Paul,
Weiss, Rifkind, Wharton &amp; Garrison LLP, 1285 Avenue of the Americas, New York, New York 10019 or through electronic exchange of documents
and signatures, unless another time, date or place is agreed to in writing by the Company and the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 40.5pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">At or prior to the Closing,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 1in; text-align: left; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Investors shall pay to the Company the Purchase Price, in cash, by wire transfer of immediately available funds, with each
Investor responsible for the portion of the Purchase Price set forth on its signature page hereto, to an account of the Company, which
account shall be designated in writing by the Company to the Investors prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 1in; text-align: left; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall issue the Purchased Securities to the Investors and subsequently cause the Purchased Securities to be registered
in book entry form in the name of the Investors on the Company stock register with the Company&rsquo;s transfer agent;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 1in; text-align: left; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> the Investors shall deliver to the Company a duly completed and executed Internal Revenue Service Form W-9 (or in the case an
Investor is a non-U.S. person, a duly completed and executed Internal Revenue Service Form W-8); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 1in; text-align: left; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">the Investors shall deliver to the Company the requested information set forth on <U>Schedule A</U>
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 40.5pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of this Purchase Agreement, &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black">business
day</FONT>&rdquo; shall mean a day, other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized
or required by law to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Further Assurances</U>. Following the Closing, the parties hereto shall execute and deliver such additional documents and take
such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the transactions contemplated
by this Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The Company represents and warrants to the Investors that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware.
The Company has all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as
presently conducted and to enter into, deliver and perform its obligations under this Purchase Agreement. The Company is duly licensed
or qualified to conduct its business and, if applicable, is in good standing under the laws of each jurisdiction (other than its jurisdiction
of incorporation) in which the conduct of its business or the ownership of its properties or assets requires such license or qualification,
except where the failure to be in good standing would not reasonably be expected to have a material adverse effect on the business, financial
condition or results of operations of the Company and its subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Purchased Securities have been duly authorized and, when issued and delivered to the Investors against full payment therefor
in accordance with the terms of this Purchase Agreement, the Purchased Securities will be validly issued, fully paid and non-assessable,
free and clear of all liens or other encumbrances (other than those arising under this Purchase Agreement or applicable securities laws
or those imposed by the Investors) and will not have been issued in violation of or subject to any preemptive or similar rights created
under the Company&rsquo;s organizational documents or contractual arrangements (as in effect at such time of issuance).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Purchase Agreement has been duly authorized, executed and delivered by the Company, with all necessary corporate approvals
obtained, and, assuming that this Purchase Agreement constitutes the valid and binding agreement of the Investors, this Purchase Agreement
is enforceable against the Company in accordance with its terms, except as may be limited or otherwise affected by (i)&nbsp;bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally
or (ii)&nbsp;principles of equity, whether considered at law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The issuance and sale by the Company of the Purchased Securities pursuant to this Purchase Agreement will not (i) conflict with
or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition
of any lien, charge or encumbrance upon any of the property or assets of the Company or any of its subsidiaries pursuant to the terms
of, any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Company or any
of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of
the Company is subject, or affect the validity of the Purchased Securities or the legal authority of the Company to comply with its obligations
under this Purchase Agreement; (ii)&nbsp;result in any violation of the provisions of the organizational documents of the Company; or
(iii)&nbsp;result in any material violation of any statute or any judgment, order, rule or regulation of any court or governmental agency
or body, domestic or foreign, having jurisdiction over the Company or any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the date hereof, the authorized capital stock of the Company consists of 45,000,000 shares of Common Stock and 3,000,000
shares of preferred stock, par value $0.001 per share. As of November 29, 2024, there were&nbsp;15,786,139&nbsp;shares of Common Stock
outstanding and no shares of preferred stock of the Company outstanding. Except as set forth in the SEC Documents (as defined below),
there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from the Company any securities of the
Company.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person
in connection with the issuance and sale of the Purchased Securities pursuant to this Purchase Agreement, other than (i)&nbsp;filings
with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;), (ii) filings required by applicable state securities laws,
(iii) those required by Nasdaq or (iv) &nbsp;the failure of which to obtain would not materially affect the Company&rsquo;s ability to
comply with its obligations under this Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Assuming the accuracy, in all material respects, of each Investor&rsquo;s representations and warranties set forth in <U>Section
5</U>, no registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), is required for the offer
and sale of the Purchased Securities by the Company to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has made available to the Investors (including via the SEC&rsquo;s EDGAR system), a true, correct and complete copy
of each form, report, statement, schedule, prospectus, proxy, registration statement and other documents filed by the Company with the
SEC prior to the date of this Purchase Agreement (the &ldquo;<U>SEC Documents</U>&rdquo;). None of the SEC Documents filed under the Exchange
Act contained when filed or, if amended prior to the date of this Purchase Agreement, as of the date of such amendment with respect to
those disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. As of the
date hereof, there are no material outstanding or unresolved comments in comment letters from the SEC staff with respect to any of the
SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any person acting on its behalf has offered or sold the Purchased Securities by any form of general solicitation
or general advertising in violation of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and listed for trading on Nasdaq. There is no suit,
action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by Nasdaq or the SEC,
respectively, to prohibit or terminate the listing of the Common Stock on Nasdaq or to deregister the Common Stock under the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board has taken all action necessary to exempt this Purchase Agreement, the Investment, the Cooperation Agreement and the transactions
contemplated hereby and thereby from the provisions of Section 203 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has filed with Nasdaq a Listing of Additional Shares Notification Form in respect of the Purchased Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company is not, and immediately after receipt of payment for the Purchased Securities, will not be, an &ldquo;investment company&rdquo;
within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company will use at least $7.0 million of the net proceeds of the Investment to repay indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Investors Representations and Warranties</U>. Each Investor, severally and not jointly, represents and warrants to the Company
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) The Investor has conducted its own investigation of the Company, the Common Stock and the other outstanding securities of the
Company, the Common Stock (including the Purchased Securities) or any other securities of the Company or the offer and sale of the Purchased
Securities or otherwise and none of such persons shall be liable to the Investor, (ii) the Investor has had access to, and an adequate
opportunity to review, financial and other information as the Investor deems necessary to make its decision to purchase the Purchased
Securities, (iii) the Investor has been offered the opportunity to ask questions of the Company and received answers thereto, as it deemed
necessary in connection with its decision to purchase the Purchased Securities and (iv) the Investor has made its own assessment and has
satisfied itself concerning the relevant tax and other economic considerations relevant to its investment in the Purchased Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor (i)&nbsp;is a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule&nbsp;144A under the Securities Act)
or (ii) an &ldquo;accredited investor&rdquo; (as defined in Rule&nbsp;501(a) under the Securities Act), in each case, satisfying the applicable requirements set forth
on <U>Schedule&nbsp;A</U> hereto. Accordingly, the Investor understands that the transactions contemplated by this Purchase Agreement
meet the exemptions from filing under FINRA Rule 5123(b)(1)(C) or (J).</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor is not purchasing the Purchased Securities with a view to, or for offer or sale in connection with, any distribution
thereof (within the meaning of the Securities Act) that would be in violation of the securities laws of the United States or any state
thereof, and the information set forth on <U>Schedule&nbsp;A</U> hereto with respect to the Investor shall be true in all respects. The
Purchased Securities to be received by the Investor hereunder will be acquired for the Investor&rsquo;s own account, not as nominee or
agent, and not with a view to the resale or distribution of any part thereof in violation of the Securities Act or other securities laws
of the United States or any state thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor is aware that the offer and sale to the Investor of the Purchased Securities is being made in reliance on the private
placement exemption from registration under Regulation D promulgated under the Securities Act and the Investor is acquiring the Purchased
Securities for the Investor&rsquo;s own account or for an account over which the Investor exercises sole discretion for another qualified
institutional buyer or accredited investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor is able to fend for itself in the transactions contemplated herein. The Investor has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risks of its prospective investment in the Purchased Securities.
The Investor has the ability to bear the economic risks of its prospective investment, and can afford the complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor acknowledges that the Purchased Securities have not been registered under the Securities Act or any other applicable
securities laws, are being offered for sale in a transaction not requiring registration under the Securities Act, and unless so registered,
the Purchased Securities may not be offered, sold or otherwise transferred except in compliance with the registration requirements of
the Securities Act and any other applicable securities laws, pursuant to any exemption therefrom or in a transaction not subject thereto.
The Investor acknowledges that any certificates or book entries representing the Purchased Securities shall contain a restrictive legend
to such effect (<U>provided</U> that such legend may be subject to removal in accordance with <U>Section 6(d)</U>). The Investor acknowledges
that the Purchased Securities will be subject to these securities law transfer restrictions and, as a result of these transfer restrictions,
the Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Purchased Securities and may be required
to bear the financial risk of an investment in the Purchased Securities for an indefinite period of time. The Investor acknowledges that
it has been advised to consult legal, tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of
any of the Purchased Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Investor is purchasing the Purchased Securities as a fiduciary or agent for one or more investor accounts, the Investor
has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations
and agreements herein on behalf of each owner of each such account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor acknowledges that the Investor has received or had access to such information as the Investor deems necessary in order
to make an investment decision with respect to the Purchased Securities, including, with respect to the Company, its other securities
and the business of the Company and its subsidiaries. The Investor acknowledges that the Investor has consulted with its own legal, accounting,
financial, regulatory, and tax advisors, to the extent deemed appropriate. Without limiting the generality of the foregoing, the Investor
acknowledges that it has had the opportunity to review the Company&rsquo;s filings with the SEC. The Investor acknowledges that it is
aware that there are substantial risks incident to the purchase and ownership of the Purchased Securities, including those set forth in
the Company&rsquo;s filings with the SEC. The Investor acknowledges that the Investor shall be responsible for any of the Investor&rsquo;s
tax liabilities that may arise as a result of the transactions contemplated by this Purchase Agreement, and that neither the Company nor
the Company&rsquo;s advisors or other representatives have provided any tax advice or any other representation or guarantee regarding
the tax consequences of the transactions contemplated by the Purchase Agreement.</P>




<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor became aware of this offering of the Purchased Securities solely by means of direct contact between the Investor and
the Company or a representative of the Company, and the Purchased Securities were offered to the Investor solely by direct contact between
the Investor and the Company or a representative of the Company. The Investor did not become aware of this offering of the Purchased Securities,
nor were the Purchased Securities offered to the Investor, by any other
means. The Investor acknowledges that the Purchased Securities (i)&nbsp;were not offered by any form of general solicitation or general
advertising and (ii)&nbsp;are not being offered in a manner involving a public offering under the Securities Act or any state securities
laws. The Investor acknowledges that the Investor has relied solely upon independent investigation made by the Investor and that it is
not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including,
without limitation, the Company or its respective affiliates or any control persons, officers, directors, employees, agents or representatives
of any of the foregoing), other than the SEC Documents and the representations and warranties of the Company expressly contained in <U>Section&nbsp;4</U>,
in making its investment or decision to invest in the Company and the Purchased Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor acknowledges that no federal or state agency has passed upon or endorsed the merits of the offering of the Purchased
Securities or made any findings or determination as to the fairness of this investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor has been duly formed or incorporated and is validly existing and is in good standing under the laws of its jurisdiction
of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The execution, delivery and performance by the Investor of this Purchase Agreement are within the powers of the Investor, have
been duly authorized and will not constitute or result in a material breach or material default under or conflict with any order, ruling
or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which
the Investor is a party or by which the Investor is bound, and will not violate any provisions of the Investor&rsquo;s organizational
documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating
agreement, as may be applicable. The signature of the Investor on this Purchase Agreement is genuine, and the signatory has legal competence
and capacity to execute the same or the signatory has been duly authorized to execute the same, and, assuming that this Purchase Agreement
constitutes the valid and binding agreement of the Company, this Purchase Agreement constitutes a legal, valid and binding obligation
of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i)&nbsp;bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally,
or (ii)&nbsp;principles of equity, whether considered at law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Investor is or is acting on behalf of (i)&nbsp;an employee benefit plan that is subject to Title&nbsp;I of the Employee
Retirement Income Security Act of 1974, as amended (&ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>ERISA</U></FONT>&rdquo;),
(ii)&nbsp;a plan, an individual retirement account or other arrangement that is subject to Section&nbsp;4975 of the Internal Revenue Code
of 1986, as amended (the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Code</U></FONT>&rdquo;),
(iii)&nbsp;an entity whose underlying assets are considered to include &ldquo;plan assets&rdquo; of any such plan, account or arrangement
described in <U>clauses&nbsp;(i)</U> and <U>(ii)</U> (each, an &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>ERISA
Plan</U></FONT>&rdquo;), or (iv)&nbsp;an employee benefit plan that is a governmental plan (as defined in Section&nbsp;3(32) of ERISA),
a church plan (as defined in Section&nbsp;3(33) of ERISA), a non-U.S. plan (as described in Section&nbsp;4(b)(4) of ERISA) or other plan
that is not subject to the foregoing <U>clauses&nbsp;(i)</U>, <U>(ii)</U> or <U>(iii)</U> but may be subject to provisions under any other
federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Similar
Laws</U></FONT>,&rdquo; and together with ERISA Plans, &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Plans</U></FONT>&rdquo;),
the Investor represents and warrants that (A)&nbsp;neither the Company nor any of its affiliates has provided investment advice or has
otherwise acted as the Plans&rsquo; fiduciary, with respect to its decision to acquire and hold the Purchased Securities, and none of
the parties to the transactions contemplated by this Purchase Agreement is or shall at any time be the Plans&rsquo; fiduciary with respect
to any decision in connection with the Investor&rsquo;s investment in the Purchased Securities; and (B)&nbsp;its purchase of the Purchased
Securities will not result in a non-exempt prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, or
any applicable Similar Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor acknowledges that, except for the SEC Documents and the representations and warranties of the Company expressly set
forth in <U>Section&nbsp;4</U>, neither the Company nor any of its affiliates or any control persons, officers, directors, employees,
agents or representatives of any of the foregoing or any other person or entity makes or has made any express or implied representation
or warranty to the Investor or any of its affiliates or representatives with respect to (i) the Company or its affiliates or their respective
securities or businesses, or any estimates, financial projections, forecasts, budgets, prospect information and other forward-looking
information or business and strategic plan information regarding the Company or its affiliates or with respect to any other information
provided or made available to the Investor or its affiliates or representatives in connection with Investment, or (ii) any oral or written
information presented to the Investor or any of its affiliates or representatives in the course of its or their due diligence investigation
of the Company and affiliates, the negotiation of this Purchase Agreement or the Investment.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company agrees to use commercially reasonable efforts to, within forty-five (45) calendar days following the Closing Date,
file with the SEC a registration statement for a shelf registration on Form S-3 (if the Company is then eligible to use a Form S-3 shelf
registration) or Form S-1 (if the Company is then not eligible to use a Form S-3 shelf registration) (the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Registration
Statement</U></FONT>&rdquo;), in each case, covering the resale of the Purchased Securities to be purchased by the Investors pursuant
to this Purchase Agreement (such shares of Common Stock and, unless issued in a transaction registered under the Securities Act, any other
equity security issued or issuable with respect to such purchased Common Stock by way of stock split, dividend, distribution, recapitalization,
merger, exchange, replacement or similar event, the &ldquo;<U>Registrable Shares</U>&rdquo;) and, if such Registration Statement does
not become effective automatically upon filing, the Company shall use its commercially reasonable efforts to have the Registration Statement
declared effective as soon as reasonably practicable after the filing thereof; <U>provided</U>, that the Company&rsquo;s obligations to
include the Registrable Shares in the Registration Statement are contingent upon the Investors furnishing in writing to the Company such
information regarding the Investors or their permitted assigns, the securities of the Company held by the Investors and the intended method
of disposition of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be reasonably requested
by the Company to effect the registration of the Registrable Shares, and the Investors shall execute such documents in connection with
such registration as the Company may reasonably request that are customary of a selling stockholder in similar situations; <U>provided</U>
that the Investors shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be
subject to any contractual restriction on the ability to transfer the Registrable Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At its expense the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except during any blackout or similar period or for such times as the Company is permitted hereunder to suspend the use of the
prospectus forming part of a Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification,
exemption or compliance under state securities laws which the Company determines to obtain, continuously effective with respect to the
Investors, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements
or omissions, until the earliest of the following: (A) the&nbsp;Investors cease to hold any Registrable Shares and (B)&nbsp;the date all
Registrable Shares held by the Investors may be sold without restriction under Rule 144 under the Securities Act. The period of time during
which the Company is required hereunder to keep a Registration Statement effective is referred to herein as the &ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Registration
Period</U></FONT>&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>during the Registration Period, promptly advise the Investors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;when a Registration Statement or any amendment thereto has been filed with the SEC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;&nbsp;after it shall receive notice or obtain knowledge thereof, of the issuance by the SEC of any stop order suspending
the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable
Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;subject to the provisions in this Purchase Agreement, of the occurrence of any event that requires the making of any changes
in any Registration Statement or prospectus so that, as of such date, the statements therein are not materially misleading and do not
omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus,
in the light of the circumstances under which they were made) not misleading. Notwithstanding anything to the contrary set forth herein,
the Company shall not, when so advising the Investors of such events, provide the Investors with any material, nonpublic information regarding
the Company other than to the extent that providing notice to the Investors of the occurrence of the events listed in <U>(1)</U>&nbsp;through
<U>(4)</U> above constitutes material, nonpublic information regarding the Company;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> during the Registration Period, use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness
of any Registration Statement as soon as reasonably practicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;during the Registration Period, upon the occurrence of any event contemplated in <U>Section&nbsp;6(b)(ii)(4)</U>, except
for such times as the Company is permitted hereunder to suspend the use of a prospectus forming part of a Registration Statement, use
its commercially reasonable efforts to, as soon as reasonably practicable, prepare a post-effective amendment to such Registration Statement
or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Registrable
Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>during the Registration Period, use its commercially reasonable efforts to cause all Registrable Shares to be listed on the national
securities exchange on which the Common Stock is then listed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt 12pt; text-align: left; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>during the Registration Period, use its commercially reasonable efforts to allow each Investor to review disclosure regarding such
Investor in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary in this Purchase Agreement, the Company shall be entitled to delay the filing or effectiveness
of, or terminate or suspend the use of, the Registration Statement (or any prospectus therein) if it determines that an amendment is legally
required to avoid a material misstatement or omission (the &ldquo;<U>Suspension Event</U>&rdquo;). Such suspension shall not exceed sixty
(60) consecutive calendar days or one hundred twenty (120) total calendar days during the twelve (12) month period following the Closing.
Upon receipt of any written notice from the Company detailing the Suspension Event, each Investor agrees to immediately discontinue offers
and sales of the Registrable Shares under the Registration Statement until the Investors receive copies of a supplemental or amended prospectus
that corrects the misstatement(s) or omission(s) and receives notice that any post-effective amendment has become effective. If so directed
by the Company, the Investors will deliver to the Company or, in each Investor&rsquo;s sole discretion, destroy all copies of the prospectus
covering the Registrable Shares in such Investor&rsquo;s possession; <U>provided</U>, that this obligation to deliver or destroy all copies
of the prospectus covering the Registrable Shares shall not apply (A)&nbsp;to the extent such Investor is required to retain a copy of
such prospectus (1)&nbsp;in order to comply with applicable legal, regulatory, self-regulatory or professional requirements or (2)&nbsp;in
accordance with a bona fide pre-existing document retention policy or (B)&nbsp;to copies stored electronically on archival servers as
a result of automatic data back-up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Purchased Securities are either eligible to be sold (i) pursuant to an effective Registration Statement or (ii) without
restriction or limitation under, and without the Company being in compliance with the current public information requirements of, Rule
144 under the Securities Act, then at an Investor&rsquo;s written request, each of the Company and the Investors will reasonably cooperate
with the Company&rsquo;s transfer agent, such that any remaining restrictive legend set forth on such Purchased Securities will be removed
in connection with a sale of such shares, subject to receipt from the Investors by the Company and its transfer agent of customary representations
and other documentation reasonably requested by the Company and its transfer agent in connection therewith, including, if required by
the Company&rsquo;s transfer agent, an opinion of counsel, in a form reasonably acceptable to its transfer agent, regarding the removal
of such restrictive legends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following such time as Rule 144 under the Securities Act is available, with a view to making available to the Investors the benefits
of Rule 144, the Company agrees, for so long as any Investor holds the Purchased Securities purchased pursuant to this Purchase Agreement,
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make and keep public information available, as those terms are understood and defined in Rule 144; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 60pt; text-align: left; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the
applicable provisions of Rule 144.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> In connection with any Registration Statement in which the Investors are participating, each Investor shall furnish (or cause
to be furnished) to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with
any such Registration Statement or Prospectus (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company agrees to indemnify, to the extent permitted by applicable law, the Investors (to the extent a seller under the Registration
Statement) and their directors and officers and each person who controls each Investor (within the meaning of the Securities Act) to the
extent permitted by applicable law, against all losses, claims, damages, liabilities and reasonable and documented out-of-pocket expenses
(including reasonable and documented outside attorneys&rsquo; fees) resulting from any untrue or alleged untrue statement of material
fact contained in or incorporated by reference in any Registration Statement, prospectus included in any Registration Statement (&ldquo;<FONT STYLE="font-variant: normal; font-weight: normal; text-transform: none; color: black"><U>Prospectus</U></FONT>&rdquo;)
or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not
misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to the Company
by or on behalf of the Investors expressly for use therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investors agree, severally and not jointly, to indemnify, to the extent permitted by applicable law, the Company, its directors
and officers and each person or entity who controls the Company (within the meaning of the Securities Act) against any losses, claims,
damages, liabilities and expenses (including, without limitation, reasonable and documented outside attorneys&rsquo; fees) resulting from
any untrue or alleged untrue statement of material fact contained or incorporated by reference in any Registration Statement, Prospectus
or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not
misleading, but only to the extent that such untrue statement or omission is contained (or not contained in, in the case of an omission)
in any information or affidavit so furnished in writing by on behalf of the Investors expressly for use therein; <U>provided</U>, that
the liability of the Investors shall be several and not joint with any other Investor and shall be in proportion to and limited to the
net proceeds received by the Investors from the sale of Registrable Shares giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any person or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim
with respect to which it seeks indemnification (<U>provided</U> that the failure to give prompt notice shall not impair any person&rsquo;s
or entity&rsquo;s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) unless
in such indemnified party&rsquo;s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist
with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to
the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made
by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all
parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party
a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party
or which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The indemnification provided for under this Purchase Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director or controlling person or entity of such indemnified party and shall
survive the transfer of the Purchased Securities purchased pursuant to this Purchase Agreement. &nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> If the indemnification provided under this <U>Section&nbsp;7</U> from the indemnifying party is unavailable or insufficient to
hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result
of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations; <U>provided</U>, that the liability of the Investors
shall be limited to the net proceeds received by the Investors from the sale of Registrable Shares giving rise to such indemnification
obligation. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things,
whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to
state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied
by, in the case of an omission), such indemnifying party or indemnified party, and the indemnifying party&rsquo;s and indemnified party&rsquo;s
relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party
as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in <U>Sections&nbsp;7(a)</U>
- <U>(c)</U> above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation
or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution pursuant to this <U>Section&nbsp;7(e)</U> from any person or entity who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Business Combination Covenant</U>. The Investors agree that, immediately upon the Investors (together with their respective
affiliates) acquiring beneficial ownership, or becoming the beneficial owner, of 21.0% or more of the outstanding shares of Common Stock
without prior Board approval, (A) the Investors (together with their respective affiliates, as applicable) shall be considered an &ldquo;interested
stockholder&rdquo; of the Company as defined in Section 203 of the DGCL (but, for this purpose, replacing 15% in such definition with
21.0%) as if the exemption from Section 203 of the DGCL pursuant to this Section 4(k) had not been granted and (B) the Company shall be
subject to the restrictions on any business combination (as defined in Section 203 of the DGCL) with the Investors (together with their
respective affiliates, as applicable) as an &ldquo;interested stockholder&rdquo; enumerated in Section 203 of the DGCL for a period of
three years following such time the Investors (together with their respective affiliates) came to beneficially own 21.0% or more of the
outstanding shares of Common Stock. For the avoidance of doubt, for purposes of the foregoing ownership limitation, it is understood and
agreed that any securities acquired or underlying any award or grant from the Company with respect to a Restricted Person&rsquo;s (as
defined in the Cooperation Agreement) service as a director, officer or employee of the Company shall be excluded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither this Purchase Agreement nor any rights that may accrue to the Investors hereunder (other than the Purchased Securities
acquired hereunder, if any) may be transferred or assigned, other than an assignment by an Investor to any of its affiliates or any fund
or account managed by the same investment manager as such Investor or an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company may request from the Investors such additional information as the Company may deem necessary to evaluate the eligibility
of each Investor to acquire the Purchased Securities and in connection with the inclusion of the Purchased Securities in the Registration
Statement, and each Investor shall promptly provide such information as may reasonably be requested, to the extent readily available and
to the extent consistent with its internal policies and procedures; <U>provided</U> that the Company agrees to keep any such information
provided by the Investors confidential, except as required by laws, rules or regulations, at the request of the staff of the SEC or another
regulatory agency or by the regulations of any applicable stock exchange. The Investors acknowledge that the Company may file a copy of
the form of this Purchase Agreement with the SEC as an exhibit to or within a current or periodic report or a registration statement of
the Company. The Investors shall be afforded the reasonable opportunity to review and provide comments to any and all such exhibits, reports
or registrations as well as to any and all Current Reports on Form 8-K related to this Purchase Agreement or the Cooperation Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investors acknowledge, severally and not jointly, that the Company will rely on the acknowledgments, understandings, agreements,
representations and warranties of the Investor contained in this Purchase Agreement.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Company and each Investor are each entitled to rely upon this Purchase Agreement and each is irrevocably authorized to produce
this Purchase Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect
to the matters covered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All of the representations and warranties contained in this Purchase Agreement shall survive the Closing. All of the covenants
and agreements made by each party hereto in this Purchase Agreement shall survive the Closing until the applicable statute of limitations
or in accordance with their respective terms, if a shorter period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Except as otherwise provided herein, this Purchase Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Without limiting any remedies of a party hereunder for a breach of this Purchase Agreement by the
other party, except as otherwise set forth in the Cooperation Agreement, each party shall pay its own costs and expenses incurred in connection
with the negotiation and execution of this Purchase Agreement and consummation of the transactions contemplated hereby, whether or not
such transactions are consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Specific Performance; Remedies; Venue; Waiver of Jury Trial</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each Investor acknowledge and agree that irreparable injury to the other party would occur in the event any of the provisions
of this Purchase Agreement were not performed in accordance with their specific terms or were otherwise breached and that such injury
would not be adequately compensable by the remedies available at law (including the payment of money damages). It is accordingly agreed
that the Company, on the one hand, and each Investor (acting individually or jointly), on the other hand, will be entitled to seek an
injunction or injunctions to prevent breaches of this Purchase Agreement and to seek to enforce specifically the terms and provisions
of this Purchase Agreement, in addition to any other remedy to which they are entitled at law or in equity. FURTHERMORE, THE COMPANY AND
EACH INVESTOR AGREES: (1) THE NON-BREACHING PARTY WILL BE ENTITLED TO INJUNCTIVE AND OTHER EQUITABLE RELIEF, WITHOUT PROOF OF ACTUAL DAMAGES;
(2) THE BREACHING PARTY WILL NOT PLEAD IN DEFENSE THERETO THAT THERE WOULD BE AN ADEQUATE REMEDY AT LAW; AND (3) THE BREACHING PARTY AGREES
TO WAIVE THE POSTING OF A BOND OR OTHER SECURITY OR BONDING REQUIREMENT UNDER ANY APPLICABLE LAW, IN THE CASE THAT ANY OTHER PARTY SEEKS
TO ENFORCE THE TERMS BY WAY OF EQUITABLE RELIEF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Purchase Agreement will be governed in all respects, including validity, interpretation, and effect, by the laws of the State of Delaware
without giving effect to the choice of law principles of such state. The Company and each Investor (i) irrevocably and unconditionally
submits to the exclusive jurisdiction of the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept
jurisdiction over a particular matter, the federal or other state courts located in Wilmington, Delaware), (ii) agrees that it will not
attempt to deny or defeat such jurisdiction by motion or other request for leave from any such court, (iii) agrees that any action or
proceeding based on, relating to, or arising in connection with this Purchase Agreement or the transactions contemplated by this Purchase
Agreement shall be brought, tried, and determined only in such courts, (iv) waives any claim of improper venue or any claim that those
courts are an inconvenient forum, and (v) agrees that it will not bring any action based on, relating to, or arising in connection with
this Purchase Agreement or the transactions contemplated by this Purchase Agreement in any court other than such courts. The parties to
this Purchase Agreement agree that the delivery of process in connection with any such action or proceeding in the manner provided in
<U>Section 15</U> or in such other manner as may be permitted by applicable law as sufficient service of process, shall be valid and sufficient
service thereof; <U>provided</U> that such process or other papers based on, relating to, or arising in connection with any such action
or proceeding is also contemporaneously delivered to the email address of such party set forth in <U>Section 15</U> (for the avoidance
of doubt, such email shall not in and of itself constitute effective service of process).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EACH
OF THE PARTIES, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY WAIVES
ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LITIGATION BASED ON, RELATING TO OR ARISING IN CONNECTION WITH THIS PURCHASE
AGREEMENT OR ANY RELATED INSTRUMENT OR AGREEMENT, OR ANY OF THE TRANSACTIONS CONTEMPLATED THEREBY, OR ANY COURSE OF CONDUCT, DEALING, STATEMENTS
(WHETHER ORAL OR WRITTEN), OR ACTIONS OF ANY OF THEM. NO PARTY SHALL SEEK TO CONSOLIDATE, BY COUNTERCLAIM OR OTHERWISE, ANY ACTION IN
WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If, at any time subsequent to the date hereof, any provision of this Purchase Agreement is held by any court
of competent jurisdiction to be illegal, void or unenforceable, such provision will be of no force and effect, but the illegality, voidness
or unenforceability of such provision will have no effect upon the legality or enforceability of any other provision of this Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Purchase Agreement may be executed in counterparts, each of which shall be deemed to be an original,
but both or all of which shall constitute the same agreement. Signatures to this Purchase Agreement transmitted by electronic mail in
&ldquo;portable document format&rdquo; (.pdf) form or by any other electronic means intended to preserve the original graphic and pictorial
appearance of a document, will have the same effect as physical delivery of the paper document bearing the original signature. For the
avoidance of doubt, no party shall be bound by any contractual obligation to the other parties until all counterparts to this Purchase
Agreement have been duly executed by each of the parties and delivered to the other parties (including by means of electronic delivery).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Waiver</U>. This Purchase Agreement may not be modified except by an instrument in writing, signed by each of the parties
hereto. No failure or delay by any party in exercising any right or remedy under this Purchase Agreement will operate as a waiver thereof
or of any breach of any provision hereof, nor will any single or partial waiver thereof preclude any other or further exercise thereof
or the exercise of any other right or remedy under this Purchase Agreement. The failure of a party to insist upon strict adherence to
any term of this Purchase Agreement on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter
to insist upon strict adherence to that term or any other term of this Purchase Agreement. No waiver shall be effective unless in writing,
executed by the waiving party. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or
remedies that they would otherwise have hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Understanding</U>. This Purchase Agreement and the Cooperation Agreement contain the entire understanding of the parties
with respect to the subject matter hereof and supersede any and all prior and contemporaneous agreements, memoranda, arrangements, and
understandings, whether written or oral, between the parties, or any of them, with respect to the subject matter of this Purchase Agreement
and the Cooperation Agreement. This Purchase Agreement shall not confer any rights or remedies upon any person other than the parties
hereto and those individuals and entities entitled to indemnification hereunder, and their respective successor and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. All notices, consents, requests, instructions, approvals and other communications provided for herein, and all
legal process in regard hereto, will be in writing and will be deemed validly given, made or served when delivered in person, by electronic
mail, by overnight courier or two Business Days after being sent by registered or certified mail (postage prepaid, return receipt requested)
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0 0 0.5in; text-align: left">If to the Investors, to the addresses
provided on the Investors&rsquo; signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0 0 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt 0.5in; text-align: left">with copies (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Olshan Frome Wolosky LLP<BR>
1325 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention: Ryan Nebel<BR>
Email: RNebel@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt 0.5in; text-align: left">If to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Red Robin Gourmet Burgers, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">10000 E. Geddes Avenue, Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Englewood, Colorado 80112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention: Sarah Mussetter, Chief Legal Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12pt">&nbsp;</P>



<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt 0.5in; text-align: left">with copies (which shall not constitute notice) to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP<BR>
1285 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention: David S. Huntington<BR>
Email: dhuntington@paulweiss.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">At any time, any party may,
by notice given in accordance with this <U>Section 15</U> to the other party, provide updated information for notices under this Purchase
Agreement. Copies delivered solely to outside counsel shall not constitute notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">[SIGNATURE PAGES FOLLOW]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Investor has executed or caused this Purchase Agreement to be executed by its duly authorized representative as of the date first
written above.</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Name of Investor:</TD>
    <TD STYLE="width: 50%">State/Country of Formation or Domicile:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:&nbsp;&nbsp;_____________________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;&nbsp;___________________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:&nbsp;&nbsp;___________________________________</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name in which Purchased Securities are to be registered (if different):</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Investor&rsquo;s EIN:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Business Address-Street:</TD>
    <TD>Mailing Address-Street (if different):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>City, State, Zip:</TD>
    <TD>City, State, Zip:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Attn:&nbsp;&nbsp;____________________________________</TD>
    <TD>Attn:&nbsp;&nbsp;____________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Telephone No.:</TD>
    <TD>Telephone No.:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Facsimile No.:<BR>
Email:</TD>
    <TD>Facsimile No.:<BR>
Email:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Number of Purchased Securities being purchased:</TD>
    <TD>___________________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Aggregate Purchase Price: $__________________</TD>
    <TD>Per Share Purchase Price: $__________________</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">You must pay the Purchase
Price by wire transfer of United States dollars in immediately available funds to the account specified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Purchase Agreement</I>]</P>

<!-- Field: Page; Sequence: 13; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has accepted this Purchase Agreement as of the date first written above.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>RED ROBIN GOURMET BURGERS, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Purchase Agreement</I>]</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">SCHEDULE A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">ELIGIBILITY REPRESENTATIONS OF THE INVESTOR</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">A.</TD>
    <TD STYLE="width: 90%">QUALIFIED INSTITUTIONAL BUYER STATUS</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Please check the applicable subparagraphs):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">We are a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule&nbsp;144A under the Securities Act).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt">OR</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">B.</TD>
    <TD STYLE="width: 90%">ACCREDITED INVESTOR STATUS</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Please check the applicable subparagraphs):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">1.</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;We are an &ldquo;accredited investor&rdquo; (within the meaning of Rule&nbsp;501(a) under the Securities Act) and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an &ldquo;accredited investor.&rdquo;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>2.</TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;We are not a natural person.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">Rule&nbsp;501(a), in relevant part, states that
an &ldquo;accredited investor&rdquo; shall mean any person who comes within any of the below listed categories, or who the issuer reasonably
believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly
qualifies as an &ldquo;accredited investor.&rdquo;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 90%; text-align: left">Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment company;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 90%; text-align: left">Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, savings and loan association, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000, or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any private business development company;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any organization described in Section&nbsp;501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any natural person whose individual net worth, or joint net worth with that person&rsquo;s spouse or spousal equivalent, exceeds $1,000,000. For purposes of calculating a natural person&rsquo;s net worth: (a) the person&rsquo;s primary residence shall not be included as an asset; (b) indebtedness that is secured by the person&rsquo;s primary residence, up to the estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding 60 calendar days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and </TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(c) indebtedness that is secured by the person&rsquo;s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 90%; text-align: left">Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person&rsquo;s spouse or spousal equivalent in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any entity in which all of the equity owners are accredited investors;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any entity of a type not listed first, second, third, fourth, ninth or tenth bullets of this section, not formed for the specific purpose of acquiring the securities offered, owning investments in excess of $5,000,000;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the Securities and Exchange Commission has designated as qualifying an individual for accredited investor status;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any natural person who is a &ldquo;knowledgeable employee&rdquo; as defined in rule 3c-5(a)(4) under the Investment Company Act of 1940 of the issuer of the securities being offered or sold where the issuer would be an investment company, as defined in section 3 of such act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7) of such act;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 90%; text-align: left">Any &ldquo;family office,&rdquo; as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, as amended, with assets under management in excess of $5,000,000, not formed to acquire the securities offered, and whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment; or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">Any &ldquo;family client,&rdquo; as defined in rule 202(a)(11)(G)-1 under the&nbsp;Investment Advisers Act of 1940, as amended, of a family office meeting the requirements set forth above and whose prospective investment in the&nbsp;issuer&nbsp;is directed by such family office pursuant to the requirements set forth above.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">3a.</TD>
    <TD STYLE="text-align: left">Please indicate whether or not the Investor is, or is acting (directly or indirectly) on behalf of, (i) an employee benefit plan (within the meaning of Section 3(3) of ERISA), whether or not such plan is subject to ERISA, (ii) a plan, individual retirement account or other arrangement that is described in Section 4975(e)(1) of the Code, whether or not such plan, account or arrangement is subject to Section 4975 of the Code, (iii) an insurance company using general account assets, if such general account assets are deemed to include the assets of any of the foregoing types of plans, accounts or arrangements for purposes of Title I of ERISA or Section 4975 of the Code under Section 401(c)(1)(A) of ERISA or the regulations promulgated thereunder, or (iv) an entity which is deemed to hold the assets of any of the foregoing types of plans, accounts or arrangements (each of the foregoing described in clauses (i), (ii), (iii) and (iv) being referred to as a &ldquo;Plan Investor&rdquo;).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 85%; text-align: left">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">No</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left">3b.</TD>
    <TD STYLE="width: 90%; text-align: left">If question 3a above was answered &ldquo;Yes,&rdquo; please indicate whether or not the Plan Investor is subject to Title I of ERISA or Section 4975 of the Code.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 85%; text-align: left">Yes</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="width: 85%; text-align: left">No</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: left">3c.</TD>
    <TD STYLE="width: 90%; text-align: left">If question 3b above was answered &ldquo;Yes,&rdquo; please indicate what percentage of the Plan Investor&rsquo;s assets invested in the Company are the assets of &ldquo;benefit plan investors&rdquo; as defined in Section 3(42) of ERISA.</TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Segoe UI Symbol,sans-serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 22.5pt"><B>__________________________%</B></TD><TD STYLE="text-align: left"></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 22.5pt; text-align: left; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 12pt 22.5pt; text-align: left; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>This page should be completed by the Investor<BR>
and constitutes a part of the Purchase Agreement.</I></P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>eh240546757_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: #231F20"><FONT STYLE="background-color: white"><B>EXHIBIT
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="background-color: white"><B>RED ROBIN GOURMET BURGERS, INC. ANNOUNCES&nbsp;INVESTMENT AND APPOINTS NEW&nbsp;INDEPENDENT DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="background-color: white"><I>JCP
Investment Management, LLC and Jumana&nbsp;Capital, LLC&nbsp;Invest An Additional $8.3 Million to Pay Down Debt and Support Strategy,
Demonstrating&nbsp;Long-term Commitment to Brand</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #231F20"><FONT STYLE="background-color: white"><I>James
C. Pappas and Christopher Martin added to Board&nbsp;of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Enters into Agreement with JCP Investment Management,
LLC&nbsp;and&nbsp;Jumana&nbsp;Capital, LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #231F20; background-color: white">ENGLEWOOD, Colo.</FONT><FONT STYLE="background-color: white">,
<FONT STYLE="color: #231F20">December&nbsp;3, 2024 </FONT>--&nbsp;Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) (&ldquo;Red Robin&rdquo;
or the &ldquo;Company&rdquo;), a full-service restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly
atmosphere, today announced that affiliates of JCP Investment Management, LLC (&ldquo;JCP&rdquo;) and Jumana Capital, LLC (&ldquo;Jumana&rdquo;)
invested&nbsp;an additional&nbsp;$8.3 million&nbsp;into the Company, strengthening&nbsp;its&nbsp;balance sheet and demonstrating their
long-term commitment to the strategy and brand. &nbsp;Additionally, the Company announced the appointment of&nbsp;James C. Pappas and
Christopher Martin to its Board of Directors (the &ldquo;Board&rdquo;), pursuant to a cooperation agreement (the &ldquo;Agreement&rdquo;)
with JCP and Jumana&nbsp;(the &ldquo;Investor Parties&rdquo;). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Upon Mr. Pappas&rsquo; and Mr. Martin&rsquo;s respective appointments,
the Board will expand to 10 directors,&nbsp;nine&nbsp;of whom&nbsp;will be&nbsp;independent. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;JCP&rsquo;s and Jumana&rsquo;s additional investments demonstrate
their commitment and belief in the future of Red Robin,&rdquo;&nbsp;said David A. Pace, Chairman of the Board. &nbsp;&nbsp;&ldquo;We are
pleased to welcome&nbsp;James and Chris&nbsp;to Red Robin&rsquo;s Board of Directors and look forward to their contributions and expertise
as we continue to&nbsp;execute on our strategy for the comeback of this beloved brand.&nbsp;James&nbsp;brings significant experience in
board roles at restaurant brands in similar phases of revitalization and&nbsp;Chris&nbsp;adds&nbsp;both industry and financial expertise
that will be important to our progress.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">Pursuant to the Agreement,&nbsp;Mr.
Pappas and Mr. Martin will be nominated by the Board to stand for election for a full term at the Company&rsquo;s 2025 Annual Meeting
of Stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Mr. Pappas stated on behalf of the Investor Parties: &ldquo;We appreciate
the dialogue we have had with Red Robin and are supportive of the Company&rsquo;s strategy and management team.&nbsp; From day one, our
focus will be to help decrease debt through our investment proceeds, increased operating cash flow and the thoughtful exploration and
consideration of other debt reduction options available, including the potential for selective franchising of some company-operated stores.&nbsp;
Strengthening the balance sheet positions Red Robin to continue to deliver fantastic and craveable burgers every day while also building
long-term shareholder value.&rdquo;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">Additionally, the Company entered
into an equity purchase agreement with certain affiliates of the Investor Parties pursuant to which the Company agreed to issue and sell
to them an aggregate of&nbsp;1,600,909 shares of the Company&rsquo;s common stock, at a purchase price of $5.19 per share, </FONT>pursuant
to a private placement (the &ldquo;Private Placement&rdquo;) that is exempt from registration under the Securities Act of 1933, as amended<FONT STYLE="background-color: white">.&nbsp;The
aggregate gross proceeds from the Private Placement are expected to be approximately $8.3 million. The net proceeds from the Private Placement
will be used to repay indebtedness and for general corporate expenses. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Additional information on the Agreement and the Private Placement can be
found in the Company&rsquo;s Form 8-K filed today with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="background-color: white"><B>About James C. Pappas </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">Mr. Pappas founded JCP Investment
Management in Houston in June 2009 and is the Managing Member and owner of the firm. </FONT>He has served as a director of United Natural
Foods, Inc. (NYSE: UNFI), a food distributor to grocery stores, since September 2023. Additionally, <FONT STYLE="background-color: white">he
has been the chairman of the board of directors of Innovative Food Holdings, Inc. (OTCQB: IVFH), a direct-to-chef and restaurant specialty
food platform, since 2023, and a director since 2020. Mr. Pappas is also a director of Tandy Leather Factory, Inc. (NASDAQ: TLF), a specialty
retailer and wholesale distributor of leather and leather related products, a position he has held since 2016. Mr. Pappas previously served
on the boards of several other public companies, including food-related businesses such as Jamba, Inc., The Pantry, Inc., and Morgan&rsquo;s
Foods, Inc., as well as </FONT>U.S. Geothermal Inc<FONT STYLE="background-color: white">. From 2007 until 2009, he was a private investor,
in addition to consulting with several businesses. From 2005 until 2007, he worked in the Investment Banking/Leveraged Finance Division
of Goldman Sachs, where he advised private equity groups and corporations on appropriate leveraged buyout, recapitalization and refinancing
alternatives. Prior to that, he was an investment banker at Banc of America Securities, where he focused on consumer and retail investment
banking. He currently also serves as Secretary for the Endowment Advisory Board of the Annunciation Greek Orthodox Church in Houston and
on the Methodist Hospital Gastro Division&rsquo;s Advisory Board in Houston. </FONT>Mr. Pappas received a BBA in Information Technology,
and a Master of Finance from Texas A&amp;M University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="background-color: white"><B>About Christopher Martin</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Mr. Martin has served as a Managing Director of Jumana Capital, LLC, a
private investment firm specializing in concentrated investments in middle market companies, since July 2020, where he is responsible
for investment strategy and execution across the portfolio, and serves as the Manager of Jumana Capital Investments LLC, an affiliated
investment entity. Previously, Mr. Martin served as a Vice President at Hastings Equity Partners, LLC, a private equity firm, from July
2017 until July 2020. Mr. Martin also previously served as the Chief Financial Officer of Specialty Welding &amp; Turnarounds, LLC, an
industrial services company, from October 2017 through January 2020. Prior to that, Mr. Martin was a Vice President at Simmons &amp; Company
International, part of the Piper Sandler Companies (NYSE: PIPR), from July 2013 to July 2017. Mr. Martin began his career at FTI Consulting,
Inc. (NYSE: FCN), a global advisory firm, in the Corporate Finance and Restructuring group. Mr. Martin holds an MBA from the University
of Texas at Austin and a BBA from Texas Christian University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Red Robin Gourmet Burgers, Inc. (<FONT STYLE="color: darkred">www.redrobin.com</FONT>),
is a casual dining restaurant chain founded in 1969 that operates through its wholly-owned subsidiary, Red Robin International, Inc.,
and under the trade name, Red Robin Gourmet Burgers and Brews. We believe nothing brings people together like burgers and fun around our
table, and no one makes moments of connection over craveable food more memorable than Red Robin. We serve a variety of burgers and mainstream
favorites to Guests of all ages in a casual, playful atmosphere. In addition to our many burger offerings, Red Robin serves a wide array
of salads, appetizers, entrees, desserts, signature beverages and Donatos&reg; pizza at select locations. It&rsquo;s now easy to enjoy Red Robin
anywhere with online ordering available for to-go, delivery and catering, or you can download our new app for easy customization, access
to the Red Robin Royalty&reg; dashboard and more. There are approximately 500 Red Robin restaurants across the United States and Canada,
including those operating under franchise agreements. Red Robin&hellip; YUMMM&reg;!</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">Forward-looking statements in this press release regarding our future
operating or financial performance, our strategy and ability to execute and drive long term shareholder value, the expected activities
in connection with the Investor Parties, and all other statements that are not historical facts are made under the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These statements are based on assumptions believed by the Company to be reasonable
and speak only as of the date on which such statements are made. Without limiting the generality of the foregoing, words such as &ldquo;expect,&rdquo;
&ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo;
&ldquo;will,&rdquo; &ldquo;outlook&rdquo; or &ldquo;estimate,&rdquo; or the negative or other variations thereof or comparable terminology are
intended to identify forward-looking statements. Except as required by law, the Company undertakes no obligation to update such statements
to reflect events or circumstances arising after such date and cautions investors not to place undue reliance on any such forward-looking
statements. Forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially
from those cautionary statements and risk factors described from time to time in the Company&rsquo;s Form 10-K, Form 10-Q, and Form 8-K reports
(including all amendments to those reports) filed with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Contacts: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>For media relations questions:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Kathleen Bush, Red Robin Gourmet Burgers, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Blue"><U>kbush@redrobin.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(303) 846-5114</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Liz DiTrapano, ICR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Blue"><U>Liz.DiTrapano@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">(203) 682-4716</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>For investor relations questions:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeff Priester, ICR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Blue"><U>Jeff.Priester@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">(332) 242-4370</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rrgb-20241203.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9qkpw7xRiXgen8uPanpcOa+IScP9xJN7yYlBsW13HfmqLy8nNQo3oCLKODDWwbIA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:RRGB="http://redrobin.com/20241203" elementFormDefault="qualified" targetNamespace="http://redrobin.com/20241203">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://redrobin.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rrgb-20241203_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rrgb-20241203_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rrgb-20241203_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rrgb-20241203_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://redrobin.com/role/Cover" xlink:href="rrgb-20241203.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://redrobin.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45529363736896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 03, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  03,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RED ROBIN GOURMET BURGERS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001171759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1573084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10000
E. Geddes Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">846-6000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RRGB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M64-LFIHQ7\!K>UX_GAF_NW;W(-5KLF-,D[<H%$G/VFD=W]MVXN]81).:C)F
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M@02Z;;?=O$.P[G*LNVNP5O2-S )@XQONT\S0+Y<75^PT;MUFN^YTL'YSG<)
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " #)0H-9EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,E"@UFJQ"(6,P$
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M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #)0H-9)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ R4*#6660>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" #)0H-9!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( ,E"@UFM;\/K[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,E"@UF97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ R4*#6;9G Y%I!   (Q$  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,E"@UF?H!OP
ML0(  .(,   -              "  :P,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ R4*#69>*NQS     $P(   L              ( !B \  %]R96QS
M+RYR96QS4$L! A0#%     @ R4*#6:K$(A8S 0  (@(   \
M ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,E"@UDD'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( ,E"@UEED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="eh240546757_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://redrobin.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="eh240546757_8k.htm">eh240546757_8k.htm</File>
    <File>rrgb-20241203.xsd</File>
    <File>rrgb-20241203_lab.xml</File>
    <File>rrgb-20241203_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eh240546757_8k.htm": {
   "nsprefix": "RRGB",
   "nsuri": "http://redrobin.com/20241203",
   "dts": {
    "inline": {
     "local": [
      "eh240546757_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rrgb-20241203.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rrgb-20241203_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rrgb-20241203_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://redrobin.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eh240546757_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eh240546757_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://redrobin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950142-24-002872-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950142-24-002872-xbrl.zip
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MGH"9WDQ]UX>XR9_B<^@3.1@GAWN/B==61TTJLGN60*[^6XZ=6ZT=:%&:[(_
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MFLX@:T7V#?T']$[!(*%A"S']Z&)NP,941?M^Z/0<L.(X.."PMK[&^]8EZ),
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M,8]NR2+<5GQ[3($ ;7R$JV1@U9EV;FC"P"$XOT@?++B8H%/!",\ >(@-P5$
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M"/U+(F^G5&,CB'+!<JT&4<G0\_; &3+9%5+*91785&9W$@K8 CXVL?9L\QY
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M)QB5V#M.*0YJ_D<GR4A\6!PH,UOG)FAUB,&/P4&/3^V=_]EM[[&;\^,.5@P
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M6]E6#$CU[1G@9G,8C=R#_P=02P,$%     @ R4*#65.2!\&19   .O<! !8
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M2[PHBX79!<YTP\"F=V!.2*)\1XU/LT3X:%O@)( $COX936<OS[H=>B'\,(V
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MUV*]<X,_,B[M;T+30,_->JMW6(G0XHQA"Y%A(JO#_F5<VX70"_Z/G70YRM;
MKD\&U7X[N(0])VB0-O\"^3.,_>[4IW %"4Q>*L&P5P:9]3KU@=PQTZ@TP*K;
ML]%X$REO*IW!+(]TAZ7Z/_2F$FP@1UX8PIR".;+JX#J/9K!&#J/$6-1'F RS
MF8IR;?Q&MN>9)!.99@NT"<+2L9!N,B]02_0<*!S30I>4'@:V/C( ?68JA=Y
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MPA!9Q:SD9>[M[.UO!S6M:#6Q.%&V2)A\<S5_Y$#'0XPO&_\XMJ$R7 N<2R)
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M5EU<!BH!'I)G:3P"50NV*[V@!XVS487<J&!?EF%?\-0J34"5AMT6_P8M!*T
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MR*\$8MX*4VY]-MX+B4^2,=OAP+M;=/?'^KD5Z(6!?FEG9,7G[I)37*<NF!=
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M [\K-Z.#G=PRN"&%:FW1#:TCU8,;?B*'  ^2FYJT-,S_*H1]6;>SS%UZTE#
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M+=D0<@&RST 4*E:!I,Q05V^0'[&@ L3%S,"Q-(I,\BXB"X,XIB0Y(LU&9\Q
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MW<C&SB[<568$"^)=[QQ;N#;!K-&=W<T ^&%YJ4.)K4FC6^MKYS.R[$WK;&K
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MS +UVG%Q&?6%#7M4F^%XD)H1I[]7N:F =8Y@<)U5R9A;H^CSQJE%XMDGH66
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MR_(O87#T&WJI=U[>^2MZI;2S?Q4,YC#K(S54"<^TCT<,OJ:O_E=&JY)$UUO
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MFRW8CPP B\!IXJ^=CPHTQIS31 &OUKU<N?,%H\+@V"^I'QF\!"L<%773(^0
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M"A56CQSG6_FFJ&.83JHP[819/9((FLZ*\;-/\PHN>39Z^F(CVMQX[B:''=B
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MOSBHL(=143XJ!M]?,5@NIMOTNY_>'>__AHSGIX]GGP[?_G]02P,$%     @
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M46?6SF"G6"+9,2\V(A/KIP#D2+8B6VM)G"N[K)]5GGH?<%[3&GA[:^J4UQ-
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M5_VN5<X-NWI,?P#!_44$^L,)_P)02P,$%     @ R4*#64<\1U J P  XPL
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M^K(*[M7K=3?U&F@).?$Y,=(U5[M]*%"AK+QX QY3(2$-%O"A+ CSX$,W<RY
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M@\^:H/\.[!MVCRDH!U\U DTW4U/'/U!+ P04    " #)0H-9%0.^.OX*  "
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M+2:-OF]HPD+ - :3T-!Z&MCOR3J14XNT(,]OB=S8,8P!>M=#?Z=M?2ZPBH.
M9HA#<+9H!J$ZRA-'%Y1N<7I/GAGOPJ<M<TV-S:0.2U,3%",68R :I1:58D]$
M_&,KSM@)3_>]4!A*UUP 5G4T-%E0=-B]@8#4<K^,+#FF62('L%Y(3*GSTPW
MK''JH>F"X@0P!Y^2U'J_I"P>29K*^P&8]@\H-K%K6F##.B^F,BAB0'L@,T4$
MJD+"P>;R1:[.Q3)I8&,;>I_P&+:[^*G%P2*D.QQ(41&&9)PGDAJW(7H8,I2N
MZ0&LZMQHLJ"(L7L#62GEJ-#[A^22QH,0J75^ -%LVO&H1 '"T7;6AX90^P3C
M*LDBG)9>KL2VK*-Y%JUK0$"[.B2&,"A0('<@+&6 8J8(\0K,OPCFPW!I*/W
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M!U!+ 0(4 Q0    ( ,E"@UG%6]64?"@  #7    2              "  0
M  !E:#(T,#4T-C<U-U\X:RYH=&U02P$"% ,4    " #)0H-94Y('P9%D   Z
M]P$ %@              @ &L*   96@R-# U-#8W-3=?97@Q,# Q+FAT;5!+
M 0(4 Q0    ( ,E"@UD5@C.H)%,  '/# 0 6              "  7&-  !E
M:#(T,#4T-C<U-U]E>#$P,#(N:'1M4$L! A0#%     @ R4*#6<_DUD$3$P
M/T$  !8              ( !R>   &5H,C0P-30V-S4W7V5X.3DP,2YH=&U0
M2P$"% ,4    " #)0H-91SQ'4"H#  #C"P  $0              @ $0]
M<G)G8BTR,#(T,3(P,RYX<V102P$"% ,4    " #)0H-9%0.^.OX*  " A@
M%0              @ %I]P  <G)G8BTR,#(T,3(P,U]L86(N>&UL4$L! A0#
M%     @ R4*#66EJ"SY6!P  U5<  !4              ( !F@(! ')R9V(M
F,C R-#$R,#-?<')E+GAM;%!+!08     !P ' -$!   C"@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>eh240546757_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rrgb-20241203.xsd" xlink:type="simple"/>
    <context id="AsOf2024-12-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001171759</identifier>
        </entity>
        <period>
            <startDate>2024-12-03</startDate>
            <endDate>2024-12-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-12-03" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-12-03" id="Fact000004">0001171759</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-12-03" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-12-03" id="Fact000010">2024-12-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-12-03" id="Fact000011">RED ROBIN GOURMET BURGERS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-12-03" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-12-03" id="Fact000013">001-34851</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-12-03" id="Fact000014">84-1573084</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-12-03" id="Fact000015">10000 E. Geddes Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-12-03" id="Fact000016">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-12-03" id="Fact000017">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-12-03" id="Fact000018">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-12-03" id="Fact000019">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-12-03" id="Fact000020">303</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-12-03" id="Fact000021">846-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-12-03" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-12-03" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-12-03" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-12-03" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-12-03" id="Fact000026">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-12-03" id="Fact000027">RRGB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-12-03" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-12-03" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
